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1. Executive summary 
This research thesis, FACTORS AFFECTING FORMULATION AND EFFICACY OF A 
SHEEP ECTOPARASITICIDE used six experimental formulations containing a range of 
excipients and a novel ectoparasiticide, AHC-2013.  
The project was conducted at Yarrandoo R&D Centre, Novartis Animal Health Australasia 
Pty Limited (NAH), Kemps Creek, Australia. The project utilized resources and personnel 
approved by NAH management, e.g. animals, animal facilities, scientific analytical equipment 
and technical support. 
Three in vivo studies in sheep were conducted to investigate efficacy, drug migration in the 
fleece and around the body (from the site of deposition), and the scourability of an 
incorporated dye from the wool – each of these associated with potential production losses of 
meat from louse infestation or of wool from residues. 
The efficacy study found no formulation fully controlled the louse populations on the sheep 
for the 20 week period required for regulatory approval (Holdsworth et al., 2006). Despite 
this, several formulations displayed efficacy above 95%; these formulations, FD 0184-sol-31, 
FD 0184-sol-32, FD 0184-sol-33 should be the preferred formulations considered for 
optimization and evaluation at equivalent and higher doses. At the evaluated dose it was 
demonstrated that even at the application site with the highest chemical concentrations there 
were small residual populations of lice. Larger populations of lice were found as 
concentrations declined rapidly away from the application site along the backline. Mean 
louse counts within the control group were reduced by 31.8% 14 days after shearing, 52.2% 
28 days from shearing and peaking at 52.5% on day 56 post-shearing. The decline in mean 
louse count started to stabilize by day 42 (51.5%) with further subtle declines up to day 56. 
This trend of population decline stopped at day 70 post-shearing when an increase in the 
mean louse population was observed.  
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It is probable this reversal in trend was due to a resumption of the surviving parasite’s 
breeding cycle, and an increase in wool length and therefore the louse habitat coupled with a 
possible reduction and/or dilution of the overall chemical residues.  
Although the spray-on application method used in the evaluation of these formulations has 
many advantages to the end consumer it is not the only option available for application and 
alternatives such as higher volume spray-on and jetting solutions should also be considered 
in optimizing drug migration. The drug residue concentrations in wool were considerably 
higher on the backline close to application site (location A), as compared to the flank 
(locations B) and belly (location C). Although there was some variation of drug 
concentrations between groups for the same location and time points, there was a trend for 
the highest drug levels being closest to the application site and reducing significantly with 
distance from this area. Drug migration was found to be relatively poor with only one 
treatment group (FD 0184-sol-030) having drug movement over 1% (Concentration B/A*100) 
from location A to location B in a 42 day period. In all other groups the total concentration 
migration was less than 1%. Drug migration from location A to location C was less than 1% in 
all groups over 42 days however drug migration from location B to C varied markedly with 
migration of up to 63% (Concentration C/B*100; FD 0184-sol-032) down to 25% (FD 0184-
sol-030). Although there was relatively good migration in concentration between the two 
locations, overall migration was poor given the relatively low levels of active being found at 
location B and C in relation to the drug concentrations found at the application area, i.e. 
location A.  
Residue depletion was slow (e.g. from days 28 to 42) so only limited conclusions can be 
drawn with regard to this parameter. Although a relatively slow drug residue depletion is 
desirable for persistent efficacy it could have potential environmental, and health and safety 
implications, which impact the Wool Harvesting Interval, Wool Rehandling Interval and 
potentially Export Slaughter Interval. 
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Each parameter is assessed by the APVMA in the course of product registration. This low 
drug depletion rate should be a consideration in the design of future residue studies and 
particularly the timing of wool collections.  
Modelling of drug concentrations in wool and relative efficacy could assist in determining 
dose however, as seen in the efficacy and residue studies although there is a clear 
relationship between louse population and drug concentration in wool within treatment group 
and in comparison to the untreated controls. Yet the response effect was quite variable 
between treatment groups and would therefore be difficult to achieve without further in vivo 
evaluation; particularly extended residue depletion data beyond 42 days post-treatment.  
As drug concentration in wool data is only available for the first 42 days from treatment and 
the overall depletion is slow it is difficult to see an efficacy response over time to drug 
concentration within group.  
All formulations were found to be scourable to AS 4054 (Australian Standards, 2003) and 
therefore commercially viable. The colouring agent used was the same in all formulations. It 
could be assumed from the consistent scourability that the active ingredient and excipients 
used did not influence binding of the colouring agent to the wool fibre. This is an important 
consideration for commercial formulations and given this finding it would be prudent to use 
the same colouring agent in any future formulations.  
 
2. Literature review 
2.1. Ectoparasites of sheep 
Two principal classes of ectoparasites, flies and lice, infest sheep in Australia and are 
primarily controlled by chemical treatment in IPM programs (Holdsworth, 2005).  This 
literature review discusses both flies and lice in terms of biology, susceptibility to infestation, 
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economic and productivity factors, treatment options, resistance and residues. 
Ectoparasiticides are discussed in terms of formulation design factors and current issues. 
Although the thesis research has a focus on louse control, the residue and scourability 
studies have implications for  future blowfly control development. The research in this project 
may be considered for future development in controlling flystrike and therefore flies have 
been included in the review of literature. The sheep blowfly Lucilia cuprina is responsible for 
over 90% of primary flystrike or cutaneous myiasis on Australian sheep (Levot, 2009), 
costing around AU$280 million p.a. in treatment and production loss in endemic areas 
(Sackett et al., 2006). Blowfly strike presents in six main forms, viz. body, crutch, poll, tail, 
pizzle and wound strikes. The parasitic flies consist of three main groups: primary strike flies, 
which initiate flystrike (L. cuprina, L. sericata, Calliphora stygia, C. augur and C. nociva), 
secondary strike flies (Chrysomya rufifacies and C. varipes), which invade areas previously 
exposed by primary flies, and tertiary strike flies, which are limited to feeding on scab 
material, do not extend the wound and therefore do not pose a pathogenic disease risk 
(Arundel & Sutherland, 1988). 
The chewing or biting louse, Bovicola ovis, is the most prevalent and economically important 
louse species infesting sheep in Australia. Bovicola ovis feed on hair and skin debris, the 
irritation inducing rubbing, which results in damaged wool, and poor wool growth.  
2.2. Biology of sheep lice 
Bovicola ovis range in body size from 1–2.5 mm and more generally between 1–1.5 mm. 
They are visible to the naked eye and are cream in colour with reddish brown stripes on their 
abdomen (Figure 1). Bovicola ovis feed on the superficial layers of the skin ingesting the 
scurf, skin secretions and bacteria (Armstrong, 2001). The life cycle is completed entirely on 
the sheep (Junk, 2010). 
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Figure 1: Bovicola ovis    
 
(photo from Joshua et al., 2010)    
Figure 2: Life cycle of Bovicola ovis 
 
(photo from Joshua et al., 2010)     
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Bovicola ovis inhabit the woolly areas of the sheep and are more commonly found along the 
backline and mid-sides of the animal. Louse eggs are attached to the wool fibres within  
6–12 mm of the skin, and the preferred egg laying environment consists of a combination of 
wool fibre and an optimum temperature of 37.5oC. Adult females lay two eggs every 3 days 
and these hatch within 10 days. The nymphs’ progress through three development stages in 
21 days (Figure 2) and the generation interval is around 34 days (Joshua et al., 2010).  
Bovicola ovis nymphs and adults can survive for a few days away from their host, but eggs 
on removed wool will not hatch, e.g. wool attached to fences. This type of transfer in the 
open paddock is of little importance but with housed sheep, the risks of contamination 
transfer are increased (Kettle et al., 1985). 
Under field conditions, B. ovis are relatively host-specific, although experimental infestations 
have been found to reproduce on Angora goats (Hallam, 1985). The main source of 
infestation to sheep is from contact with other sheep and to a much lesser degree, fomites, 
such as contaminated shearing equipment and fencing. Cleland et al. (1989) found a slow 
spread of infestation after several parasitized sheep entered a louse-free population of 
sheep. A period of 69 weeks elapsed before moderate to heavy louse burdens were 
established in the experimental flock and a mesh fence separating mobs was an effective 
barrier to louse transmission (Cleland et al., 1989). Therefore, eradication may be possible 
under some well-defined circumstances, which include effective treatment, isolation and 
monitoring. 
2.3. Susceptibility to infestation  
The susceptibility of sheep to louse infestation is influenced by breed, age, health, nutrition 
and presence of disease. Within breed, individual susceptibility traits of sheep can vary, 
however generally Merinos are more susceptible to louse challenge than other breeds and 
younger animals, i.e. lambs are more susceptible than older sheep. Younger animals with 
poor growth rates or in stressed conditions through for example, disease or nutritional 
deficiencies, generally carry the heaviest infestations in a flock (James et al., 1998). 
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2.4. Economic and productivity costs of louse infestation 
An independent report prepared on behalf of Meat and Livestock Australia identified that  
B. ovis cost the Australian sheep industry an estimated AU$123 million annually through an 
increase in production costs of $84 million (e.g. fence repair, treatment, monitoring and 
management) and $39 million being attributed to a reduction in producer income from 
reduced wool quality and quantity (e.g. fleece weight and fleece value). The cost to industry 
has reduced from an estimated $169 million in 1995 due primarily to a change in structure 
and size of the national sheep flock, and changes in treatment strategies (Sackett et al., 
2006). A national survey conducted in 2004 found B. ovis was present in (mean) 20% of the 
national flock, ranging from 10–41% over the 1300 wool growers surveyed (James, 2011a).  
Irritation caused by feeding lice can increase skin secretion and yolk (suint and wool grease 
secretions). The skin secretions, which are released from the combination of rubbing, biting 
and louse feeding, cause a yellow discoloration of the fleece (Figure 3; Joshua et al., 2010). 
Figure 3: Wool derangement and yellow discoloration of fleece 
 
(photo from Joshua et al., 2010) 
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The skin irritation causes the host animal to bite and rub in an attempt to rid themselves of 
the parasite and inflammation. If the louse population is large this irritation can result in 
physical damage to the fleece through the sheep’s actions, which results in the loss of wool 
through rubbing against objects, e.g. fences, self-plucking and fleece derangement  
(Figures 3 and 4). The plucking of wool also reduces the time the sheep spends grazing. 
Figure 4: Wool derangement  
 
(photo from Joshua et al., 2010) 
An increase of yolk content can reduce the clean wool yield following the scouring process. 
Cleland et al. (1989) demonstrated the value of wool was significantly reduced due to 
increased ‘cottedness’, which reflects the level of matting and entanglement of the wool 
fibres and a lower washing yield. In the study conducted by Cleland et al. (1989), 52 of 100 
sheep infested were found to have cotted fleece, and the washing yield was 73% in the 
control group (non-infested animals) compared to 67% in the infested group. Wilkinson et al. 
(1982) found in a repeated study over 3 years that greasy fleece weight reductions were 
between 0.2 kg and 0.9 kg per animal. Niven & Pritchard (1985) reported that louse 
infestations reduced greasy fleece weights between 0.4 kg and 1.1 kg. The three studies 
confirmed that lice have no effect on wool fibre diameter.  
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In comparison, greasy fleece weight, clean fleece weight and fibre length were reduced but 
body weight was unaffected by louse burden (Wilkinson, 1982). Wilkinson (1982) also 
identified cheesy gland (Corynebacterium pyogenes) as an economic cost associated with 
louse infestation due to reduced carcass value. Although louse infestation does not directly 
induce cheesy gland, the bringing of sheep into close confines facilitates disease movement 
between them. 
Levot (2009) described the principal financial losses of louse infestation as a reduced wool 
cut of approximately 10%, which was equivalent to AU$12 per animal for fine wool sheep 
through cotted wool, decreased tensile staple strength, yellow discoloration, hide damage 
through ‘cockling’ and the increased susceptibility of flystrike. Cockling is a disorder within 
the skin that presents as small lumps, which negatively impacts the tanning process through 
not allowing dye to be taken up evenly resulting in an unattractive pelt. This unevenness 
results in significant down grading of skin value (Heath et al., 1995).  
Joshua (2010) estimated the total cost of treatment at AU$2–3 per animal. Compared to 
Levot’s estimates in the same year, Joshua (2010) used wool prices from the Australian 
Wool Exchange (16 December 2009) to calculate a production loss of AU$10.51 per sheep 
(4 kg of 18 micron wool MF3E at $11.42/kg = $45.68 per fleece compared to 3.6 kg of MF3E 
(cotted) at $9.77/kg for a $35.17 fleece). Medium wool Merino sheep had a calculated loss of 
$11.94 per head for the same period (7 kg of 23 micron wool MF5E at $8.50/kg = $59.50) 
per fleece compared to 6.3 kg of MF5E (cotted) at $7.55/kg = $47.56 per fleece). Both 
estimates of financial loss for fine wool are very similar as  reduced wool cut, cottedness, 
reduced tensile strength and wool discoloration are considered as the principal factors in 
devaluation of wool. 
2.5. Biology of sheep blowflies 
Lucilia cuprina (the Australian sheep blowfly; Figure 5) has adapted to become an obligate 
parasite of sheep and is considered the primary strike fly of sheep in Australia. 
Student No.: 200280002 
Scott Leigh Hackett 
December 2015 
 
Page 19 of 104 
 
 
Predominately all other fly species initiate secondary attacks following the initial strike by  
L. cuprina. This adaptation is thought to be a response to its poor performance as a 
competitor in carcass feeding particularly against Calliphora species (Levot, 2009).  
Although L. cuprina is an obligate parasite of sheep it can survive and develop on other 
species where tissue devitalisation is present. Persistent populations have been found 
around Darwin and in other parts of northern Australia where sheep grazing does not occur 
(Norris, 1990). 
Figure 5: Lucilia cuprina 
 
(photo from Levot, 2009) 
Lucilia cuprina has a limited dispersion range of approximately 1–2 km from where they 
hatch and therefore strikes will generally occur from flies, which have maintained their life 
cycle on the same property (Vogt and Woodburn, 1979). Fly activity favours wind speeds 
<30 kph (Graham and Junk, 2008).  
Lucilia cuprina is active in the temperature range between 17 and 35oC. In ideal conditions 
(approximately 28oC), eggs may hatch within 12–14 hours from lay; however, hatching time 
can range between 8 hours and 3 days (Levot, 2009).  
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Blowfly strike ‘waves’ can occur on farms and are generally triggered by on-going warm 
weather and rainfall inducing the hatching of flies. Under these environmental conditions a 
number of breeding cycles (generations) may occur in the one season combined with a 
higher rate of sheep susceptibility to strike (James, 2011b). 
The life cycle of L. cuprina is defined in Figure 6. 
Figure 6: Life cycle of Lucilia cuprina 
 
(photo from Levot, 2009) 
Larval development after egg hatching goes through three instars with the first instar 
requiring a protein meal for further development. The first instar feed is reliant on bacterial 
infected, damaged or inflamed skin as it is incapable of penetrating healthy skin to extract its 
first protein feed. The second and third instars can actively damage the skin using serrated 
mouthparts to feed (Figure 6). After 4–6 days on the host, the engorged third star larvae will 
drop to the ground, burrow into the soil and later pupate in a protected environment. 
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Figure 7: Blowfly larvae (maggot) development on the sheep 
 
(photo from Flyboss, 2014b)  
The third instars will normally drop off the sheep at night, which concentrates the non-
parasitic stage of the life cycle in localized areas, for example, where the sheep camp 
(Arundel & Sutherland, 1988). The prepupal stage will not progress unless temperatures are 
above 15oC, enabling a seasonal synchronization, which occurs when soil temperatures rise 
in spring triggering pupation. Where temperatures are below 15oC, e.g. going into winter, and 
pupation is delayed the term ‘overwintering’ may be applied. Overwintering can increase the 
mortality of pupae by up to 90% in some seasons through factors such as drowning, 
predation, parasitism and freezing. Levot (2009) describes pupation as reorganization of the 
tissues to form the adult fly structure and under optimal conditions adult flies will emerge 
within 6–10 days. When consistent optimal temperatures (28oC) and moisture are 
experienced, the fly’s life cycle from egg to adult development takes 11–12 days with minimal 
mortality (Levot, 2009). 
Other blowfly species include C. stygia (native brown blowfly), which generally has a higher 
prevalence over spring and autumn as it prefers cooler conditions.  
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This species tends to target the crutch area when moisture, dags (faecal material attached to 
the wool) or stains are present. Calliphora augur (lesser brown blowfly) mostly occurs over 
summer and is capable of laying live instars generally into areas that may be more easily 
accessed by the larvae, e.g. open wounds. The major secondary blowfly of interest is  
C. rufifacies (green hairy-maggot blowfly) whose larvae appear ‘hairy’ due to the presence of 
spines on their back. The larval instar is the largest of all fly species and grows to 14 mm in 
length when mature. These instars will feed on the instars of other blowfly species and 
therefore reduce larvae on the host. However, C. rufifacies do cause considerable damage to 
skin and underlying tissue (Levot, 2009). 
2.6. Susceptibility to infestation  
Blowflies are attracted to areas on the sheep’s body that are affected by the presence of 
urine, faeces or existing wounds. Fleece rot or mycotic dermatitis can also be a catalyst for 
blowfly strike (Graham and Junk, 2008). These areas are a protein rich source of food for the 
flies. Faecal staining of the breech can be caused through scouring (with or without dag 
formation with faeces binding to wool around the breech) caused by new or established 
gastrointestinal nematode parasitism associated with parasites such as Ostertagia, 
Nematodirus and Trichostrongylus (James, 2011b). 
Skin wrinkle has a genetic component and is a major predisposing factor on susceptibility of 
sheep to blowfly strike, and particularly for breech strike. Prior to the introduction of an 
operation known as ‘mulesing’, 90% of strikes were on the breech and wrinkly sheep proved 
to be 5–10 times more susceptible to strike that their plain-bodied cohorts. Although 
mulesing is effective in reducing the incidence of flystrike, genetic gains in breeding for 
breech strike minimization or even resistance to strike are more permanent and cost effective 
solutions to mulesing, although slower to introduce (Richards et al., 2009). 
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2.7. Economic and productivity costs of flystrike 
Flystrike historically became an economic and veterinary problem soon after the introduction 
of L. cuprina into Australia in the late 1800s. Lucilia cuprina is thought to have been 
introduced from South Africa or India with the incidence of disease following its distribution 
into sheep growing areas across Australia (Arundel & Sutherland, 1988). The fly had, by the 
mid-1900s, a recorded presence in most parts of the rural mainland (Waterhouse and 
Paramonov, 1950). Tasmania was the last grazing area of Australia to become infested 
(Ryan, 1954). 
In more recent times it has been estimated that flystrike costs Australian producers AU$280 
million annually through a decrease in income of $83 million coupled with an increase in 
producer expenses of $147 million (Sackett et al., 2006). Factors considered to affect 
productivity include: 
 Reduced fibre diameter, fleece weight and staple length of fleece  
 Increased mortality 
 Reduced fertility 
 Human resource requirements for treatment and monitoring for strikes 
 Cost of treatments including preventative and curative therapies.  
Flystrikes are likely to be fatal unless treated. The burrowing activity of the instars, which 
occurs during a strike, will result in the animal experiencing fever. The increase in body 
temperature results in serious breaks in the wool, which reduces the usability of the wool and 
its value (MSD Agvet, 1987). Generally sheep affected by flystrike will not show any signs 
until there are enough maggots to cause the sheep discomfort resulting in plucking-like, 
fidgety behaviour. As the infestation spreads the affected fleece becomes blackened from 
wound discharge and there is subsequent wool loss. Further disease progression reduces 
appetite and the desire to openly graze. More flies become attracted to the initial strike area 
and the sheep can die from ammonia poisoning within 3–6 days (Vetent, 2014). 
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It was suggested by Broadmeadow et al. (1984) that flystrike causes the death of up to three 
million sheep annually. However since this time, farmers have gained access to highly 
effective drugs that can successfully prevent the development of strikes. 
Treatment is relatively cost effective in comparison to the economic and veterinary costs 
associated with flystrike. For a typical preventative short wool spray-on application such as 
CLiK® Spray-On (NAH), the cost per animal is approximately AU$2.50 for a 41–50 kg animal 
or alternatively for a typical jetting product such as Vetrazin® Liquid (NAH) approximately 
$0.34 per animal for an animal with more than 6 weeks wool growth but less than 6 months 
(Flyboss, 2014a). 
2.8. Treatment options for sheep lice and sheep blowfly 
Historically, louse treatment has involved an annual application of an ectoparasiticide 
following shearing either as plunge, shower or spray dips and more recently by topical 
backline preparations (Holdsworth, 2005). James (2011a) describes a move away from this 
single approach to one of IPM; the key areas of IPM are: 
 Monitoring and detection of lice  
 Prevention of new louse infestations  
 Strategically using effective chemicals to eradicate or treat lice when they are 
present. 
Similar IPM approaches to fly control include: 
 Monitoring of fly pressure and strike 
 Timing of shearing and crutching 
 Dag management 
 Breech modification 
 Breeding and selection 
 Strategic chemical use ((Flyboss, 2014b). 
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IPM utilizes chemical therapy as one part of the management of ectoparasites on sheep, 
principally to delay the development of parasiticide resistance. Depending on the parasites 
involved, an IPM approach could include biological and environmental controls, genetic 
improvement and management options (Evans, 2001). In the case of louse control this is 
often restricted to timing of treatment and the quarantine treatment of incoming stock. 
However preventing infestation through adequate fencing, restriction of straying stock, buffer 
zones, non-sheep vector management, early detection, lambing cycle and timing of shearing 
all contribute to an integrated approach to louse control (Wood et al., 2003). 
In the case of blowfly control, non-treatment management options could include mulesing, 
tail docking to the correct length, nematode control, strategic crutching, matching timing of 
shearing and lambing, genetic improvement through reducing breech/body wrinkle and 
selecting for fleece rot resistance. A good understanding of the blowfly life cycle, monitoring 
the blowfly population with fly traps and treating affected sheep in a timely way can help to 
manage the increase in population (Evans, 2001).  
There are currently seven main chemical classes available to control and/or treat sheep lice 
and blowflies: 
 Organophosphates: Diazinon e.g. Eureka Gold® (Coopers® Animal Health), 
temephos e.g. Assassin® (Coopers Animal Health), Wham® (Agvantage Animal 
Health) (Junk G, 2010). The organophosphates work by over-activation of the 
neuromuscular junctions by phosphorylation and consequent inhibition of acetyl 
cholinesterase, which ultimately result in paralysis of the parasite (Levot, 1995). 
 Synthetic pyrethroids: Cypermethrin e.g. Clout-S® (Coopers Animal Health), alpha-
cypermethrin e.g. Vanquish® (Coopers Animal Health) (MIMS, 2014). Synthetic 
pyrethroids cause hyperpolarization of neuronal membranes by preventing closure of 
sodium channels. Both central and peripheral neurotoxic effects have been observed.  
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At a lethal dose, synthetic pyrethroids cause paralysis and death whereas sub-lethal 
doses will inhibit feeding, oviposition and have repellent effects towards some target 
species (Kettle et al., 1985). 
 Insect growth regulators include triazines, cyromazine e.g. Vetrazin, pyrimidine-
derivatives, dicyclanil e.g. CLiK, benzoyl phenyl-ureas, diflubenzuron e.g. Magnum® 
(Coopers Animal Health) and triflumuron e.g. Zapp® (Bayer Animal Health) (MIMS, 
2014).  
Most IGRs are used prophylactically for either louse or fly control although some have 
activity against both parasites. As the common name suggests these classes of drug 
interfere with the development and growth of juvenile parasites. For example, cyromazine, 
which is used for blowfly control acts against the first and second instars by preventing 
moulting. IGRs interrupt arthropod-specific growth mechanisms, including the metabolism 
and deposition of chitin into the exoskeleton (Graf, 1999). 
 Macrocyclic lactones: Ivermectin e.g. Coopers Blowfly and Lice Jetting Fluid® 
(Coopers Animal Health) (Junk, 2010). Ivermectin stimulates the inhibitory 
neurotransmitter gamma-aminobutyric acid from proximal nerve endings at synapses 
and causes its binding to the post-synaptic receptors, which results in paralysis and 
death (Kettle et al., 1985).  
 Spinosyns: Spinosad e.g. Extinosad® (Elanco Animal Health) (Junk, 2010). 
Spinosyns have neurotoxic effects, albeit with a different mode of action and site of 
action to other drug classes. The spinosyns target binding sites on nicotinic 
acetylcholine receptors and this binding leads to disruption of acetylcholine 
neurotransmission. Spinosad also has secondary effects as a gamma-aminobutyric 
acid neurotransmitter agonist. Spinosyns kill insects via hyperexcitation of the insect 
nervous system (Orr et al., 2009). 
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 Neonicotinoids: Imidacloprid e.g. Avenge®, thiacloprid e.g. Piranha® (Bayer Animal 
Health) (Junk, 2010). The neonicotinoids are a group of fast-acting nicotinyl binding 
receptor insecticides, which disrupt normal nerve communication within the central 
nervous system of the louse. This targeted disruption results in paralysis and death of 
the parasite (Cotter, 2013). 
 Magnesium fluorosilicate e.g. Flockmaster® II (Junk, 2010) and other related 
compounds, quickly and severely dehydrate lice. Magnesium fluorosilicate is 
approved for organic production (Wood et al., 2003). 
2.9. Issues for ectoparasiticides: 
2.9.1. Ectoparasiticide resistance 
Various levels of pest resistance exists to the available chemical classes (Table 1, page 33). 
Synthetic pyrethroids and benzoyl phenyl-ureas are now considered highly ineffective 
against many louse populations. Laboratory bioassays based on the successful hatching of 
eggs, laid by diflubenzuron-exposed B. ovis, to produce nymphs confirmed benzoyl phenyl-
urea-resistance and strong cross-resistance has been identified between triflumuron and 
diflubenzuron (Levot and Sales, 2008). Additional bioassay testing of two strains where pen 
based trials had established resistance confirmed resistance factors of 67x and 94x (James 
et al., 2008).  
The IGR group of chemicals accounted for 80% of the short wool, off-shears lousicide market 
in the mid-2000s (Evans, 2006). Backline applications such as these are now considered 
prone to the development of resistance through either inappropriate application of the 
formulation on the backline and/or the influence of spreadability over the sheep resulting in 
sub-optimal chemical concentration gradients through the fleece. This influences efficacy and 
subjects the lice to sub-lethal drug concentrations that fosters resistance development 
(James, 2011c).  
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Similarly reports of product failure in louse control were considered to be drug resistance 
until further investigation found that poor spreadability or movement of organophosphates 
through the wool and therefore around the sheep’s body impacted drug efficacy. There is a 
paucity of published literature concerning the critical evaluation of backliner and spot-on 
formulations. Residue studies therefore are an ideal way to best understand the migratory 
behaviour of the formulations in the wool following treatment; this is moreso as formulation 
development becomes more novel. This information will be used in the selection process for 
identifying any promising formulations for further research and development. 
Drug resistance to organophosphates in L. cuprina populations has been confirmed from as 
early as 1965, and 2 decades ago 97–98% of fly populations were affected (Levot, 1995). 
Kotze et al., (1997) found monooxygenase enzyme activity (aldrin epoxidation) in 19 field-
collected strains of the Australian sheep blowfly varied over a 46-fold range however, 
monooxygenase activity had significantly related toxicological responses to diflubenzuron 
and diazinon. Diflubenzuron concentration response decreased as enzyme activity increased 
suggesting that a proportion of the larval population that could tolerate high rates of 
diflubenzuron had increasing enzyme levels. Tolerance levels to diflubenzuron among the 
field strains (relative to a reference susceptible strain) were up to 10-fold at LC50 and 56-fold 
at LC95 (Kotze et al., 1997). 
The use of organophosphates has now been restricted and historical jetting and dipping 
practices have become illegal unless conducted under a special permit. This change in 
approach is primarily due to the human and environmental safety concerns associated with 
organophosphate use (Wood et al., 2003). 
Resistance in B. ovis or L. cuprina has not yet been reported for the spinosyns, macrocyclic 
lactones and the minimally used magnesium fluorosilicate (Junk, 2010). 
Strategic use of effective ectoparasite treatments is a critical component of an IPM program 
and for resistance management. Historical resistance to synthetic pyrethroid and IGR 
classes has occurred through the repeated use of one chemical class.  
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It is suggested a regular rotation between the avaliable chemical classes, e.g. spinosyns, 
neonicotinoids, organophosphates and triflumuron or diflubenzuron would reduce the 
likelihood of resistance development.  
Correct application of ectoparasiticides is a critical component of effective louse control, and 
factors that influence the effectiveneess of application include the method of application, 
applicator choice, dose and pattern of application (James and Levot, 2014). 
2.9.2 Application methods  
Applications methods include plunge dipping, which involves sheep swimming through a 
chemical solution. Sheep are effectively saturated and should ideally have 3 weeks wool 
length at time of treatment. The advantage of this application is that saturation is achievable 
and therefore effectiveness is high (Wood et al., 2003). The disadvantages are that it 
requires capital investment to set up or reliance on contractor services, it is labour intensive, 
there are risks of bacterial infection, and chemical concentrations needs to be maintained 
(Kettle et al., 1985). Chemical concentrations in dipping solutions can be an issue as many 
chemicals are lipophilic and are therefore absorbed into the wool and/or ‘stripped’ from the 
dip solution in dirt (Holdsworth, 2005).  
Shower dips also work by saturating the sheep through a low pressure ‘shower’ application 
of dilute chemical solution. Each animal may be exposed to approximately 30–50 L of 
solution with approximately 5% of this volume being carried away by the sheep following 
dipping (Kettle et al., 1985) but saturation and therefore effective control is harder to achieve 
in comparison to plunging (Wood et al., 2003).  As saturation is difficult to achieve and dose 
variation is high, these factors could lead to resistance and undesirable residues in wool and 
meat. In additon, as a considerable volume of formulation is used in dipping application there 
are human safety exposure risks through potential dermal, oral and inhalation routes to dip 
operators. There are also environmental implications as formulations are carried away by the 
sheep following treatment and there is run-off from the dipping process, which may find its 
way in waterways (Kettle et al., 1985). 
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Jetting is used in situations for louse control where wool length is greater than 6 weeks. It is 
also used for preventing and treating flystrike. Jetting uses high pressure jets, which spray 
the chemical solution into the wool. Jetting fluid may be applied either through a spray race 
(with variable results) or by hand (done properly provides very good results) (Holdsworth, 
2005). Disadvantages of this application method, and particularly in the case of hand-jetting 
is the high labour cost and possible increased wool residue issues through overdosing 
(Wood et al., 2003). 
The development of low volume pour-on technology brought about a significant reduction in 
labour requirements for ectoparasite control compared with jetting and plunge dipping 
techniques. Typically this method uses a small volume of a concentrated chemical 
formulation that is applied over the backline of the sheep. The application method first 
emerged with the development of synthetic pyrethroids, where formulations were developed 
for off-shears and long wool treatments (Kettle et al., 1985). An advantage of pour-on 
treatments is convenience as the formulations are ‘ready-to-use’, i.e. no water is required 
and they can be applied from a backpack and gun similar to those used for anthelmintics. 
There is no bacterial risk, e.g. dermatitis in the wool. Some pour-ons can be applied off-
shears thereby presenting  a reduced risk to the environment as there is no run-off from the 
sheep. In addition the formulations contain a dye, which is readily identifiable to the farmer to 
confirm treatment. The pour-on application was typically applied on the backline following 
shearing in a narrow application band (Bayvel et al.,1981).  
Although the pour-on method has many advantages, the narrow application pattern over the 
backline may present a risk whereby the majority of the applied chemical (e.g. deltamethrin) 
stays within the application site and that drug residues markedly declined moving away from 
the application area (Johnson et al., 1995). Using autoradiography in the assessment of a 
pour-on formulation of cypermethrin, Johnson et al. (1991) determined that the initial 
formulation spread was rapid and moved eight centimetres from the treatment area within 24 
hours.  
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The formulation also penetrated the stratum corneum primarily at the site of application. In 
the case of deltamethrin (a more lipophilic compound), there was potentially reduced mobility 
due to poor diffusion down the wool fibre (Hennessy, 1997). Hennessy (1997) recommended 
that applying topical lousicide formulations directly along the backline immediately after 
shearing maximises and evens the diffusion of formulation around the sheep flanks to 
contact lice inhabiting sites remote from the point of chemical formulation. As fleeces are 
essentially open structures comprising approximately 95% of open space, diffusion through 
the fleece is more closely linked or dependent on diffusion down the staple of the fleece 
(Rakin, 2005). Hennessy (1997) also reported a ‘canopy-like effect’ from pour-on application 
whereby a chemical formulation (containing deltamethrin) stayed on the growing tip of the 
wool allowing parasite re-establishment in the area of wool between the tip and skin that was 
not coated with drug to any great extent. James (2002) suggested that the high prevalence of 
lice experienced in most states of the country during the middle of the 1990s could be related 
to resistance to synthetic pyrethroid pour-on treatments, which at the time accounted for 
almost 70% of lousicides.  
In an attempt to mitigate this through a broader application band, a new type of applicator 
was developed and sold when triflumuron was launched under the trade name of Zapp 
(Bayer Animal Health). The new T-bar applicator had a wider boom with a number of spray 
jets to more effectively distribute the formulation over the backline (Griffin, 1993). Although a 
wider application pattern assisted in formulation distribution over the animal, drug 
concentrations were still highest in the treatment area with limited movement of the 
formulation around the body of the sheep (Levot & Sales, 2008). 
Similarly with the development and launch of Vetrazin® Spray-On, CLiK® and MAGiK® for 
blowfly prevention and louse control (latter for MAGiK only), new spray-on formulations and 
applicators were implemented. The spray-on further widened the application band width to 
improve drug distribution around the animal.  
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Two studies examined the fate of dicyclanil (CLiK) in wool during the period immediately 
following spray-on application to sheep. The first study progressed for 20 weeks and 
monitored dicyclanil (and metabolite) concentrations in the wool. From the treated backline 
were these concentrations ranged 10.9–13.7 g/kg (Smal and Chaophrasy, 1996). In the 
second study, which ran for 46 weeks, drug concentrations in wool from the treated backline 
were ranged 4.92–8.58 g/kg (Kearney & Ochudzawa, 1996). In both studies, drug 
concentrations in wool from the flanks, which had not been directly treated, were much lower 
0.37–0.39 g/kg following treatment in the 20 week study and 0.29–0.34 g/kg in the 46 week 
study at the same time point.  
As seen in other pour-on type formulations, drug concentrations in the fleece were 
concentrated in the area where the formulations were applied, but lower levels were detected 
in untreated areas, indicating some spread within the fleece away from the application area. 
The wider spray-on application increases the application area and therefore improves the 
overall distribution of the formulation over the animal. However drug migration from this 
application area is critical for overall drug efficacy. 
2.9.3 Drug residues 
Drug residues in wool present an on-going issue to the sheep industry at all levels from farm 
worker/shearer, to processor and ultimately the end-use customer. This is evident in the 
potential for health risks to workers from mishandling product and/or treated animals.  
The management and cost of pesticide residues remaining in scour effluent is an 
environmental and compliance issue for wool processors. There is also a trend of customer 
preference towards more sustainable and environmentally ‘friendly’ products. Wool residues 
therefore remain an important area of investigation for the sheep industry and one that 
remains under continued scrutiny by veterinary regulators (Holdsworth, 2005). The APVMA 
recently completed a review (APVMA, 2014) of all registered sheep ectoparasiticides to 
address the following areas of concern:  
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 Occupational health of workers, particularly shearers, who may come into contact 
with treated wool, specifically during shearing or wool harvesting. 
 The potential of chemical residues to harm vulnerable organisms in the environment, 
particularly if the chemicals are released as part of wool processing. 
 The potential of chemical residues on treated wool to influence trade, particularly 
where overseas wool processing plants discharge scour effluent into the aquatic 
environment. 
The outcomes of this review have seen a revision of all product labels to ensure these areas 
have been adequately addressed. 
As part of this review the wool withholding period terminology has been changed to the Wool 
Harvesting Interval, which defines the period between treatment of the animal and the 
harvesting of wool.  
After the assessment undertaken by the Office of Chemical Safety, labels now require a 
Rehandling Period to prevent residue exposure to workers. The APVMA has also determined 
it will not be possible to set specific trade-related Wool Harvesting Intervals for sheep 
ectoparasiticide products to ensure that residues on exported wool meet importing country 
requirements, particularly in the European Union (APVMA, 2014).  
The purpose of the wool residue and scourability study in this research thesis was to provide 
new and critical information on the drug concentration and formulation persistence in wool 
following treatment. Junk (2010) encouraged wool growers to reduce their dependence on 
ectoparasite treatments, through an IPM approach, which has the benefit of increased 
market access for residue free wool (EU Eco-label limit), reduced workplace safety risks and 
reduced production costs. 
Potential human health, resistance and drug residues risks are summarized and tabulated 
below for all chemical classes excluding the neonicotinoid class, which includes imidacloprid 
and thiacloprid.  
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This class of chemicals has no known drug resistance in sheep lice or blowfies to date 
(Liceboss, 2014). Human health risks are relatively low and the Wool Harvesting Interval is 6 
months (Farmadvisor, 2014).  
Table 1: Potential risks (drug residue, user safety and resistance) 
 
(from Junk, 2010) 
Student No.: 200280002 
Scott Leigh Hackett 
December 2015 
 
Page 35 of 104 
 
 
In addition to following the MSDS and label, the regulatory framework sets out legal 
obligations to minimize the risk of human safety, environmental and drug residues. These 
include the requirement for chemical users to be appropriately trained and supervised in their 
use and to read and follow the label instructions (The Pesticides Act (1999) and Work Health 
and Safety Legislation and Regulations). In addition, from July 2002 under The Pesticides 
Act (1999) it is a legal requirement to keep records of all pesticide applications. Where 
applicable the pesticide records may also be used in the completion of National Vendor 
Declarations and Sheep Health Statements when animals are transported or sold (Junk, 
2010). 
The APVMA through the regulatory review process attempts to provide producers with 
access to effective ectoparasiticides while at the same time ensuring the health and safety of 
people, market access and trade, and that the environment is adequately protected. This is 
done through a risk management approach, which involves careful scientific evaluation of 
tissue and wool residues, occupational health and safety, trade, dietary exposure and 
environmental safety (APVMA, 2014). 
2.10. Formulation design and testing of effective ectoparasiticides  
Depending on their intended purpose, topical formulations are designed for (i) facilitated 
transdermal drug absorption, or (ii) retention on the wool with minimal absorption. These  
so-called ‘pour-on or spot-on’ formulations are usually developed as solutions, suspensions 
or less commonly emulsions. Generally the active ingredient concentration in these 
formulations is high and hence a smaller dose volume is typically applied to a localized area 
on the animal.  
Barriers to absorption of a topical formulation on sheep include wool and hair follicles. As an 
example, Merino sheep have 300–400 primary (sebaceous gland, sweat gland, erector pili 
muscles) and 6000–10,000 secondary hair follicles (sebaceous gland only) per cm2 in the 
wool growing areas, which includes backline and flanks.  
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The hair and wool is composed of the modified protein, keratin that consists of chemically 
reactive groups including thiol, amino and carboxyl groups. This and the pattern of fibre 
growth are important when designing veterinary drug formulations because they influence 
the binding of the drug, thermodynamics, and diffusion of the emulsion of sweat and sebum 
on the follicle (Pittman & Rostas, 1981). Generally dissipation is higher on coarse wool and 
open fleeces (e.g. breeds of British origin) compared to the finer, closed fleece breeds such 
as the Merino. This is due to an increased exposure of the formulation (and specifically the 
active ingredient) to the elements (e.g. sun, rain and dirt). However the physical 
characteristics of the active ingredient and formulation also have a strong influence,  
e.g. organophosphates have a half-life in the wool of 4–5 weeks, synthetic pyrethroids have 
14–15 weeks, diflubenzuron and triflumuron have 14–18 weeks, and the triazine group of 
IGRs, approximately 4 weeks (Savage, 1998). Once the wool is shorn and baled there is 
very little chemical dissipation occurring. Farmers require ectoparasiticide formulations to be 
long-acting particularly for flystrike prevention and the only way to achieve this is to have 
residues persisting in the wool.  
Many ectoparasiticides are lipophilic and typically absorbed in the wax component of the 
wool. Once the wool has been harvested and scoured the chemical is removed with the wax, 
suint and other containments. Lipophilic formulations tend to remain in the wax and therefore 
present a potential contamination risk. The scouring process removes approximately 30% of 
the wax from the scouring effluent; therefore both the scouring effluent and lanolin recovered 
are potential sources of concentrated chemical residues, which need to be considered in 
environmental and human safety assessments. Following the scouring process, residual 
active ingredient present on the wool fibre is removed during secondary processing and wool 
dyeing. Thus the fibre itself generally presents a low risk of chemical contamination (Savage, 
1998). 
Cyromazine, dicyclanil and magnesium fluorosilicate are currently the only available 
ectoparasiticide formulations available with appreciable water solubility (Savage, 1998). 
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Dicyclanil uses a ‘suspoemulsion’ technology in a ready-to-use formulation with the 
suspending liquid primarily consisting of water, giving the product improved safety and 
environmental characteristics (Novartis, 2001). 
The marketing requirement to have a formulation that may be systemically absorbed gives 
the potential to control both internal and external parasites or to attack an ectoparasite from 
the blood. More commonly however, in farm animal ectoparasite treatments, the active 
ingredient demonstrates efficacy through direct contact with the target parasite(s). This is 
particularly important when trying to control B. ovis that do not feed on blood (Pittman & 
Rostas, 1981). As distinct from less common face louse Linognathus ovillus and foot louse  
L. pedalis, which do feed on the blood of their host (Kettle et al., 1985). 
Eureka Gold (Coopers Animal Health) is an organophosphate-based formulation (diazinon) 
used as an off-shears, spray-on, backline lice treatment. The formulation is supplied as a 
concentrate however it must be diluted (1 part of Eureka Gold to 6 parts of water) before use. 
It is applied using a specialized power doser applicator that delivers a high volume dose  
(150 mL for an animal up to 50 kg) efficiently while ensuring good body coverage. Eureka 
Gold is applied in a band from the poll along the backline to the end of the tail. In 
comparison, Zapp Pour-On (triflumuron) is a low volume pour-on formulation applied on 
shorn sheep up to 7 days off-shears (20 mL for an animal up to 55 kg) in a single strip down 
the middle of the back between the poll and the end of the tail using an applicator with a wide 
band nozzle (Farmadvisor, 2013). 
Both Eureka Gold and Zapp, like other lousicide topical applications, contain visible dyes to 
allow the farmer to see which animals have been treated. The dye must be scourable from 
the wool as this is a critical aspect for wool processing. Formulation dyes for backline 
ectoparasiticide applications are a very important visual indicator for farmers who are 
applying the treatment in the field.  
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The dye allows for timely and effective identification of animals treated. This is particularly 
relevant for a lousicide treatment where the treatment usually involves hundreds of animals 
being treated at the one time point and the treatment of every animal is critical to effective 
parasite control.  
Historically, Pittman & Rostas (1981) described pour-on or spray-on formulations as usually 
consisting of a wettable powder in water or light mineral oils usually composed of a wetting 
agent, a dispersing agent and an inert carrier such as clay. Suspensions can also contain 
light paraffin liquid or other mineral oils or oil-based water immiscible active solutions. 
Although these elements are generally poor solvents they act very well to hold the active in 
the wool or on the animal’s skin (Pittman & Rostas, 1981). In the case of an effective 
lousicide this is an important element as drug efficacy needs to be demonstrated for a period 
of up to 20 weeks therefore drug persistence on the animal is important. Other solvents, 
which have been employed to enhance movement or absorption, include dimethyl sulfoxide-
aromatic hydrocarbon, dimethyl sulfoxide-amyl alcohol and various isopropanol-based 
solvents.  
More recently, James (2011c) assessed the feasibility of using tea tree oil as an 
ectoparasiticide treatment against B. ovis and L. cuprina. Combinations of oil with water, 
emulsifiers and carriers were used in early laboratory assays and later for animal 
applications. Important characteristics considered in the formulations prepared (5%, 2.15% 
and 1.5% tea tree oil) included their capability to stabilize the tea tree oil into an emulsion, 
the ability to wet the wool for spreadability and the rate of evaporation of the active from the 
formulation. James (2011c) found solubilisation of the active with the formulation was most 
efficient where emulsifiers with similar lipophilicity to the active ingredient were used. In wool 
dipping assays using tea tree oil it was found that a 1% concentration caused 100% mortality 
of louse adults and nymphs (James, 2011c). 
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The effectiveness of absorption or spread of the formulation and active ingredients in 
ectoparasiticide preparation in topical sheep applications is limited by the diffusion coefficient 
through the wool.  
The diffusion coefficient (i) increases as the concentration of diffusant increases, (ii) 
increases as the degree of cross-linking in the polymers decreases, (iii) decreases as the 
size of the diffusing molecule increases, and (iv) increases as the temperature increases; 
about two to five times for each 20oC (Rankin, 2005). 
As there are a number of chemical classes used for ectoparasiticide there is a range of molar 
volumes and lipophilicities and as anticipated, these display a range of diffusion 
characteristics in wool. The larger the molar volume the higher expected diffusion coefficient 
in the wool grease (Rankin, 2005). 
Details of the ingredients (excipients) used in the formulations tested in this project is 
business confidential information and cannot be disclosed in this thesis.  
2.11. Tests for efficacy and resistance 
A claim of efficacy maybe one of control or eradication and for either claim there must be 
statistically significant differences in louse populations of the control and treated groups. 
Where the claim of eradication is to be applied as in the scope of the current project, efficacy 
data must be generated to demonstrate the removal of all lice and viable eggs from treated 
sheep. Where a louse management claim is required the efficacy data must be generated to 
demonstrate the test product can reduce the louse population by more than 95% after  
90 days (Holdsworth et al., 2006).   
Drug resistance within a  B. ovis population results from the survival and reproduction of lice 
surviving exposure to the ectoparasiticide. This is influenced by factors such as the original 
concentration of the chemical, the frequency of the original mutation in the population, mode 
of inheritance of the resistance allele(s), i.e. dominant, recessive etc., amount of ‘refugia’ and 
selective pressure of treatment frequency.  
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To assess the resistance status of B. ovis, James (2008) used a laboratory assay where lice 
were collected using a vacuum pump, contained overnight on an ‘untreated lice diet’, which 
consisted of a medium prepared from pieces of ground skin with the wool and hair removed. 
A combination of diet and wool was placed into culture tubes, which were spiked with 
diflubenzuron or triflumuron mixed with acetone. Ten third-instar nymphs were added and  
9–13 days following exposure treated and non-treated control tubes were assessed for lice. It 
was confirmed resistance to diflubenzuron was present in at least two strains of lice 
assessed with estimated resistance ratios of 67–94 using the LC50 as the measurement 
point. 
Similar contact type bioassays have been used to quantify resistance to cypermethrin 
(Hughes, 1990). Levot (2008) used the same bioassay methodology as Hughes for spinosad, 
whereby strains of lice resistant to cypermethrin, diflubenzuron and triflumuron, and 
organophosphates were used to evaluate the resistance status and cross-resistance status 
of spinosad. Lice were assessed 16–18 hours post-treatment and in addition the speed of kill 
was assessed at 0.5, 1, 2, 4, 6 and 8 hours post-treatment. It was found spinosad was 
effective against all strains resistant to the other chemical classes with no evidence of cross-
resistance. However, the effectiveness of any formulations evaluated using the bioassay 
technique is based on the parasite coming in contact with and or ingesting the test treatment 
(Levot, 2008). 
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3. Objectives 
The aim of the project was to assess the efficacy, spread and scourability of an 
ectoparasiticide in six formulations with different excipients or compounding ‘vehicles’.  
Study 1 determined the efficacy of formulations containing AHC-2013 against natural 
infestations of B. ovis when administered topically to sheep off-shears and under conditions 
required for any subsequent registration. The efficacy study design took into consideration 
the World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P) 
guidelines for evaluating the efficacy of ectoparasiticides against biting lice, sucking lice and 
sheep keds on ruminants (Holdsworth et al., 2006).   
The objective of Study 2 was to acquire a dynamic understanding of the concentrations of 
AHC-2013 residues as the drug migrated from the site of application (the backline). This was 
accomplished by measuring drug concentrations in wool, sampled from pre-determined body 
locations and time points, following a single topical spray-on application of the experimental 
formulations at a dose of 5 mg/kg.  
Study 3 examined the scourability of the dye used in the AHC-2013 experimental 
formulations from wool sampled at pre-determined time points following a single topical 
spray-on application. This study aimed to ensure that residues were scourable for 
manufacture.  
This research would ultimately assist in deciding on a final formulation for development by 
providing a better understanding of the efficacy, movement in wool of AHC-2013 and 
scourability of the colouring agent. Migration of new or existing ectoparasiticides around the 
sheep’s body is important for achieving control of sheep lice. The current state of scientific 
knowledge does not provide acceptable alternatives, in vitro or otherwise, to the use of 
sheep to accomplish the purpose of these studies. All three studies were approved by the 
Novartis Animal Health Ethics Committee and approval numbers were respectively  
YAR-13-027, YAR-13-058 and YAR-13-059. 
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4. Materials and methods 
4.1. Animal selection, housing and management 
In each experiment, Merino sheep aged between 8 months and 3 years of age were used. All 
sheep were individually identified with two ear tags and were not exposed to any topical 
medication treatments within 6 months of the studies. All animals were weighed and clinically 
examined to ensure good health before being acclimatized to the animal pens and feed for  
1 week prior to their experiment starting. In accordance with the WAAVP guidelines 
(Holdsworth et al., 2006), an off-shears formulation must be administered within 24 hours of 
shearing. If a short wool claim is to be established a study must be conducted in animals with 
a wool length >24 hours up to 6 weeks post-shearing and a long wool claim is >6 weeks. 
Animals were selected in consideration of these criteria. 
For study 1, sheep were housed by treatment group in partially covered pens with steel mesh 
flooring. For studies 2 and 3, sheep were housed by treatment group in fully covered pens 
with equally-sized areas of steel mesh flooring and a deep litter system (e.g. straw, sawdust). 
For all studies these areas were inspected daily and cleaned weekly. Each pen was 
identified by a unique number. Signage on each pen included study number, initials of the 
responsible Study Director and Study Person (Biological), and the tag numbers of the sheep 
housed in the pen.   
Sheep were offered daily a ‘roughage’ mix at 3% of body weight/sheep/day as a minimum. 
This offering was consistent between pens of sheep. The roughage mix was prepared  
on-site from raw materials including lucerne/legume-based hay, oaten hay, pasture hay, feed 
grade barley, a mineral vitamin premix and flossy salt. 
For studies 1 and 3, food intake was observed but not measured. For study 2, food intake 
was measured on a daily basis from day -7 and calculated weekly.  
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Food intake was measured for each group by offering a measured amount of feed using a 
calibrated bucket (in the morning) and weighing the residual food left in the feeding trough 
the following morning, and calculating the difference. For all studies, all animals had ad 
libitum access to drinking water provided from the town supply system. No medications were 
administered in the water during the study. Sheep were monitored for any pain or stress by 
experienced animal handlers, a veterinarian and the Animal Welfare Officer. 
 4.2. Experimental design, treatment and sample method 
The experiments evaluated the following formulations (Table 2): 
Table 2: Formulations (and treatment groups for Study 1) 
Group Treatment Dose (mg/kg)* 
1 Untreated control Nil 
2 FD 0184-sol-030 5  
3 FD 0184-sol-031 5  
4 FD 0184-sol-032 5  
5 FD 0184-sol-033 5  
6 FD 0184-sol-034 5  
7 FD 0184-sol-035 5  
*5 mg/mL concentration of active ingredient 
In all studies the treatment application bands applied to sheep with a spray-on applicator are 
defined in Table 3 relative to the corresponding body weight. 
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Table 3: Proposed commercial banding table  
Body weight (kg) Number of bands 
10–20 2 
21–30 3 
31–40 4 
41–50 4 
51–60 4 
61–70 5 
71 and above 5 
For all studies the product was applied over the backline of the sheep with the first band 
being applied from poll to shoulder (approximately) and subsequent bands being evenly 
applied from shoulder to rump or rump to shoulder.  
4.3. Study 1 (efficacy) 
The experiment commenced on 25 September 2013 and concluded on 19 February 2014. A 
total of 35 Merino sheep aged 8 months to 3 years (three ewes and 32 wethers [castrated 
males]) were selected out of an initial pool of 40 sheep from a specifically infested flock at 
the study site. Animals had not been treated with lousicides over the previous 12 months. 
The sheep were selected to have moderate–high louse burdens on day -5. The general 
guide for a moderate burden is 1–5 lice per wool parting (on average) with a minimum total of 
40 lice counted in 40 wool parts while a high burden is an average of >5 lice per wool 
parting. The actual total louse count per animal on day -5 ranged from 116 to 1020. Animals 
were randomly assigned on louse count and body weight to seven treatment groups, each of 
five sheep, using an in-house randomization program ‘Sheep-sorter’.  
The sheep were treated to their individual live weights as determined on day -1. No rounding 
of live weight occurred during the calculation of the dose, which was administered to the 
sheep by volume at a dose of 1 mL/kg of body weight.  
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The sheep in Groups 2, 6 and 7 were removed from the study following the day 56 louse 
assessment due to reduced efficacy. The remaining Groups 1, 3, 4 and 5 remained in the 
study until its completion at 20 weeks post-treatment. No wool samples were taken as part of 
the efficacy study. 
4.4. Study 2 (wool residues) 
The experiment commenced on 2 October 2013 and was completed on 28 April 2014. Thirty 
sheep received a physical examination by a veterinarian and body weight measurement on 
day -14. Twenty-four animals were selected from an initial 30 and were allocated to 
treatment groups on day -13. Animals were allocated to six treatment groups with each group 
consisting of four animals. The sheep were randomized by body weight and allocated to the 
treatment groups using Sheep-sorter. 
Table 4: Treatment groups 
Group Formulation 
Duration/method of 
administration 
Time of wool collection post-
administration of test item (days) 
1 FD0184-sol-030 Single/Topical 14, 21, 28, 42 
2 FD0184-sol-031 Single/Topical 14, 21, 28, 42 
3 FD0184-sol-032 Single/Topical 14, 21, 28, 42 
4 FD0184-sol-033 Single/Topical 14, 21, 28 ,42 
5 FD0184-sol-034 Single/Topical 14, 21, 28, 42 
6 FD0184-sol-035 Single/Topical 14, 21, 28, 42 
 
This study investigated drug residues in wool after the sheep were dosed at 5 mg/kg body 
weight. Sheep were treated as per Study 1 and detailed in Section 4.2. The biological phase 
was 42 days in duration during which time the sheep were wool-sampled at pre-defined 
times (Table 4) from pre-defined locations (Figure 8) and pre-defined regions (Figure 9). 
Wool length was measured prior to wool collection, using an engineer’s rule. Wool collected 
from the pre-treatment shearing was analysed for fibre diameter and retained.  
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To minimize contamination, disposable gloves were worn whilst measuring wool length and 
collecting wool specimens, and the shearer changed pants and gloves between groups. To 
further minimize the risk of contamination between groups, the shearing hand piece was 
thoroughly cleaned with acetone and the shearing comb and cutter was changed between 
groups.  
Wool samples were analysed for AHC-2013 residues after samples were taken from: 
 Region 1:  Backline (A), Flanks (B) and Belly (C) on day 14 
 Region 2:  Backline (A), Flanks (B) and Belly (C) on day 21 
 Region 3:  Backline (A), Flanks (B) and Belly (C) on day 28 
 Region 4:  Backline (A), Flanks (B) and Belly (C) on day 42. 
Figure 8: Wool sample locations 
 
 
A 
B B 
C 
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Figure 9: Wool sample regions 
 
Figure 10: Residue sample collection 
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Figure 11: Residue sampled sheep 
 
4.5. Study 3 (scourability) 
The experiment commenced on 14 November 2013 and was completed on 28 May 2014. 
The study examined the persistence of colour and scourability of dye from the wool of treated 
sheep. Twenty two sheep were initially assessed on day -14, which included a physical 
examination by a veterinarian and the measurement of body weight. Eighteen animals out of 
the 22 were allocated to treatment groups on day -13 based on satisfactory physical 
examination and body weight between 35–70 kg.  
Sheep housing and animal randomization were the same as described for Study 2. 
Sheep were assigned to six treatment groups (Table 5); each consisting of three animals. 
Sheep were dosed according to Table 6 using a spray-on applicator, off-shears. 
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Table 5: Treatment groups 
Group Test item 
Duration/method 
of 
administration 
Time of wool collection post-administration 
of test item 
(days) 
1 FD0184-sol-030 Single/Topical 42, 70, 98 
2 FD0184-sol-031 Single/Topical 42, 70, 98 
3 FD0184-sol-032 Single/Topical 42, 70, 98 
4 FD0184-sol-033 Single/Topical 42, 70, 98 
5 FD0184-sol-034 Single/Topical 42, 70, 98 
6 FD0184-sol-035 Single/Topical 42, 70, 98 
Table 6:  Dosing table – volume of test item for appropriate body weight 
Body weight (kg)* Test item (mL) Number of bands Band volume (mL) 
10–20 20 2 10 
21–30 30 3 10 
31–40 40 4 10 
41–50 50 4 12.5 
51–60 60 4 15 
61–70 70 5 14 
71 and above # 5 # 
* Body weight was rounded up to the nearest whole kg. 
# Add 1mL/kg of body weight above 70 kg and administer total volume as five equal volume bands. 
 
Wool was sampled in bands running parallel to the sheep’s spine (i.e. where the test items 
had been applied) and between the rump and the shoulders (Figure 12). As in Study 2, in an 
effort to minimize contamination, disposable gloves were worn whilst measuring wool length 
and collecting wool specimens. The shearer changed pants and gloves between groups. To 
further minimize the risk of contamination between groups the shearing hand piece was 
thoroughly cleaned with acetone. The shearing comb and cutter was changed between 
groups. Control wool samples were taken from all animals prior to treatment.  
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Figure 12: Wool sample location 
 
 
 
Wool specimens were given a uniquely numbered label before weighing and preparation for 
transport and storage. Each specimen label included the following details: specimen number, 
study number, animal number, group number, time after treatment and sampling date. 
A duplicate sample was retained at Yarrandoo and stored at room temperature; 
approximately 25oC.  
Wool specimens weighed more than 30 g and each sample was placed in a large 
polyethylene bag as illustrated in Figure 13. Homogenization of wool samples was carried 
out by AWTA upon receipt of the samples. 
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Figure 13: Labelled sample 
 
4.6. Assessment methods 
4.6.1. Assessment of louse burdens 
Control (untreated) sheep were assessed before treated groups to reduce the risk of 
chemical contamination of the animal handling facilities. Sheep were individually restrained in 
a head bail to allow safe and effective access to the louse assessors on both sides of the 
sheep. The overall total body population of lice was evaluated through the inspection of 40 
sites or wool partings around the sheep. Figure 14 illustrates the inspection sites, which were 
placed at relatively even intervals on both sides of the sheep. At the inspection site, the wool 
was parted to a point where the skin was visible. Each inspection site was approximately  
10 cm long in a vertical direction. All live lice were counted within the wool parting from skin 
base to wool staple tip. The development stage of the lice counted was recorded, e.g. nymph 
or adult. 
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Figure 14: Louse assessment locations 
 
(figure from www.apvma.gov.au/ last accessed 13May2014) 
4.6.2. Assessment of efficacy 
The regulatory definition for control off-shears (<24 hours between shearing and treatment) 
in sheep is 100% efficacy at 20 weeks. Efficacy of the formulations was determined by 
calculating the reduction in the louse population between treated and untreated groups of 
sheep at each time point. 
Calculations of efficacy were determined using the formula: 
% efficacy = 100 x (1–[(Ta x Cb)/(Tb x Ca)]) 
Where, 
Ta = mean louse count on treated animals after treatment 
Tb = mean louse count on treated animals before treatment (i.e. day 0, pre-treatment) 
Ca = mean louse count on untreated animals after treatment day 
Cb = mean louse count on untreated animals before treatment day (i.e. day 0, pre-
treatment). 
Arithmetic means were calculated for all assessment points, with the arithmetic data being 
used for the primary calculation of efficacy.   
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4.6.3. Assessment of drug residues in wool 
Wool specimens were stored frozen at approximately -20oC before and after analysis. Prior 
to analysis wool samples were allowed to equilibrate to ambient conditions. Wool specimens 
were analysed for AHC-2013 residues using a prequalified analytical method as described 
below.  
A 1 g wool sample was pressed in a 5 mL syringe with a syringe plunger leaving a ~1 mm 
gap from the bottom. Wool blank samples were spiked with standard or QC solution (100 µL) 
for calibration curve or QC samples in blank wool samples. In all samples except double 
blank and analyte blank samples, 20 µL of internal standard solution was added. The syringe 
was then set on an SPE manifold and washed with acetonitrile (in total 10 mL). The first 
wash was 2 mL and followed by 1 mL x8 of acetonitrile. The sample was allowed to soak for 
2 to 5 minutes before the next acetonitrile loading. Acetonitrile extract was collected in a  
15 mL graduated centrifuge plastic tube. After last loading, the manifold was under vacuum 
to extract as much of the acetonitrile into the centrifuge tube as possible. Following the 
extraction process the centrifuge tube was filled to the 10 mL mark with acetonitrile. The 
centrifuge tube was capped and the tube vortexed for 10 to 30 seconds. A 200 µL extract 
was transferred into a 1.5 mL Eppendorf tube containing 800 µL of 40% acetonitrile:water 
(40:60 v/v). The Eppendorf tube was vortexed, then the extract was filtered (nylon filter,  
13 mm x 0.22 µm) into a 2 mL UPLC glass vial and 10 µL of each extract was injected onto a 
UPLC-MS/MS instrument.  
All data was calculated using the Waters UPLC-MS/MS, software MassLynx 4.1. Linearity of 
matrix matched calibration standards were calculated by linear regression, origin excluded, 
and 1/x2 weighting.  
Concentrations of AHC-2013 in the wool specimens were determined by interpolation from 
the best fit linear regression equation of matrix matched calibration standards. Accuracy and 
processed data were imported into Microsoft Office Excel 2010 spreadsheets and tabulated.   
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The performance of the analytical method was assessed via QC samples, which were freshly 
prepared and extracted at the same time as the study samples. Sets of QCs containing each 
of the four concentration levels, at least in duplicate or more, were placed amongst study 
samples throughout the analytical run. Six calibration standards were freshly prepared in 
duplicate over the range 20.0–2000 µg/kg and one replicate from each concentration was 
analysed at the beginning and at the end of the analytical sequence. Both replicates (12 in 
total) were used to construct the calibration curve. 
4.6.4. Assessment of scourability 
All wool specimens were analysed under the Australian Standard 4054-1992 for low and high 
temperature scourability (Standards Australia, 2003). The analytics were conducted at the 
AWTA Laboratory in Kensington, Victoria (Figure 15). The method used for sample treatment 
and collection deviated from the standard method described in paragraphs 5.3 and 5.4 of the 
Australian Standard 4054-1992. The deviation from the standard in this experiment more 
rigorously tested the formulations on sheep in an environment as close as possible to farm 
conditions. A numerical stain rating scale of 1 to 5 was used to characterise a pass or fail 
scourable result. A pass result means the sample was scourable and to achieve a pass 
result a sample must achieve a final staining scale rating of >4. 
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Figure 15: Scouring branding substances for greasy wool method  
 
(from Standards Australia, 1992) 
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4.6.5. Statistical methods 
4.6.5.1. Study 1 
The normal distribution assumptions for log-transformed parameters in the applied 
RMANOVA model were checked (Shapiro-Wilk test). RMANOVA methods were applied to 
louse count for control and treated groups on days 0, 14, 56, 98 and 140. The model was 
used to evaluate the interaction effect of treatment and day.  
4.6.5.2. Study 2 
Repeated measurement analysis of variance (RMANOVA) including a group (with six levels: 
1 to 6), day (with four levels: 14, 21, 28 and 42), location (with three levels: A, B and C) effect 
together with the interaction effects group by day, group by location, day by location and the 
three-way interaction group by day by location were performed on the AHC-2013 residue 
concentrations after log-transformation. This model was used in order to evaluate the 
influence of group, day and location on the AHC-2013 concentrations.  
The Normal distribution assumptions for log-transformed parameters in the applied 
RMANOVA model were checked (Shapiro-Wilk test).  
Mean residue profiles were represented on original and log-scale.  
The level of significance tests was α = 5%; all tests were performed two-sided. The statistical 
unit was the experimental group. SAS® procedure gplot was applied for graphical 
representations. All calculations were carried out on the NAH Development Biostatistics IT 
infrastructure, PC AHCHBS-L13411, using the software SAS, Version 9.2 (2008). 
Microsoft Office Excel 2010 was used for the data transfer. Summary statistics including 
arithmetic and geometric means, standard deviations, CV, median, minimum, maximum were 
provided for the mentioned parameters with respect to treatment groups and sampling 
locations as well as for the drug residue concentrations profiles. 
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4.6.5.3. Study 3 
There was no formal statistical analysis for Study 3. 
5. Results 
5.1. Study 1 (efficacy) 
The formulations were well tolerated by the sheep with no reactions observed at any stage of 
the study that were considered to be related to the application of the products. Live weights 
recorded throughout the study are summarised in Table 21 Appendix 3. No concomitant 
treatments were administered during this study. 
The arithmetic mean louse counts for all groups and the percentage efficacy of each 
treatment group were calculated (Tables 7 and 8). 
Table 7: Arithmetic mean louse counts 
Formulation 
Study day 
0 14 28 42 56 70 82 98 112 126 140 
Control 269 184 129 131 128 133 217 252 183 385 317 
FD 0184-sol-030 248 30.6 16.2 28.4 12.2       
FD 0184-sol-031 260 3.0 7.6 1.4 5.0 5.6 2.8 6.2 4.8 3.6 6.6 
FD 0184-sol-032 211 11.6 1.0 6.8 2.4 0.6 1.6 1.8 0.2 7.4 2.8 
FD 0184-sol-033 236 8.4 9.0 3.4 5.6 10.8 10.8 20.8 15.4 33.4 32.0 
FD 0184-sol-034 279 53.2 34.8 43.6 27.8       
FD 0184-sol-035 355 15.8 28.6 10.0 19.8       
All treated groups (2–7) had lice observed at each assessment post-treatment. Both nymphs 
and adult lice were observed on the treated groups post-treatment indicating treatment had 
no effect on the eggs present at treatment and/or the breeding capacity of the parasites. 
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Table 8: Efficacy (%) of topical AHC-2013 formulations 
 Study day 
Formulation 14 28 42 56 70 82 98 112 126 140 
FD 0184-sol-030 81.9 86.3 76.3 89.6 * * * * * * 
FD 0184-sol-031 98.3 93.9 98.9 95.9 95.6 98.7 97.4 97.3 99.0 97.8 
FD 0184-sol-032 91.9 99.0 93.4 97.6 99.4 99.1 99.1 99.9 97.5 98.9 
FD 0184-sol-033 94.8 92.0 97.0 95.0 90.7 94.3 90.6 90.4 90.1 88.5 
FD 0184-sol-034 72.0 73.9 67.7 79.0 * * * * * * 
FD 0184-sol-035 93.5 83.1 94.2 88.2 * * * * * * 
* Sheep were removed from the study at day 60. 
 
Formulations FD 0184-sol-31, FD 0184-sol-32, FD 0184-sol-33 (Groups 3, 4 and 5, 
respectively) were the most effective at controlling the louse populations in this study. 
Efficacy for FD 0184-sol-31 ranged from 93.9% on day 28 to 97.8% on day 140 peaking at 
99.0% on day 126. Efficacy for FD 0184-sol-32 ranged from 91.9% on day 14 to 98.9% on 
day 140 peaking at 99.9% on day 112. Efficacy for FD 0184-sol-33 ranged from 94.8% on 
day 14 through to 88.5% on day 140 peaking at 97.0% on day 42. 
Statistical analysis of the louse counts between treatment groups was assessed for days 0, 
14, 56, 98 and 140 using RMANOVA.  A normality of data test (Shapiro–Wilks test) was used 
but was not significant (p = 0.1457) indicating that the log transformed results were normally 
distributed.  
Table 9 shows the results of the RMANOVA. There was a significant effect of treatment on 
louse counts F (6,236) = 72.74 p < 0.0001. There was a significant effect of day on louse 
counts F (10,236) = 23.77 p < 0.0001. There was also an significant interaction effect of 
treatment and day on louse counts F (42,236) =1.47 p < 0.05. 
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Table 9:  Repeated measures ANOVA  
Effect Num DF Den DF F Value Pr > F 
tmt 6 236 72.74 <.0001 
day 10 236 23.77 <.0001 
tmt*day 42 236 1.47 0.039 
Table 10 shows the comparisons between groups at pre-treatment lice counts at day 0, 
knockdown at day 14, removal of groups (2, 6, 7) at day 56 and days 90 and 140 with 
significant results highlighted in bold. For clarity: 
Formulation Group 
Control 1 
FD 0184-sol-030 2 
FD 0184-sol-031 3 
FD 0184-sol-032 4 
FD 0184-sol-033 5 
FD 0184-sol-034 6 
FD 0184-sol-035 7 
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Table 10:  Pairwise group comparisons 
Day Group s Group DF t Value Pr > |t| 
Pre-
treatment 
Day 0 
1 2 236 0.21 0.831 
1 3 236 0.16 0.8732 
1 4 236 0.55 0.5862 
1 5 236 0.19 0.8531 
1 6 236 -0.08 0.9382 
1 7 236 -0.1 0.9243 
2 3 236 -0.05 0.9571 
2 4 236 0.33 0.7406 
2 5 236 -0.03 0.9775 
2 6 236 -0.29 0.7711 
2 7 236 -0.31 0.7578 
3 4 236 0.39 0.7004 
3 5 236 0.03 0.9796 
3 6 236 -0.24 0.8125 
3 7 236 -0.25 0.799 
4 5 236 -0.36 0.7194 
4 6 236 -0.62 0.5341 
4 7 236 -0.64 0.5227 
5 6 236 -0.26 0.7928 
5 7 236 -0.28 0.7794 
6 7 236 -0.02 0.9861 
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Table 10:  Pairwise group comparisons (contd) 
Day Group s Group DF t Value Pr > |t| 
Day 14 
1 2 236 3.57 0.0004 
1 3 236 6.03 <.0001 
1 4 236 4.51 <.0001 
1 5 236 4.68 <.0001 
1 6 236 2.45 0.015 
1 7 236 3.54 0.0005 
2 3 236 2.46 0.0145 
2 4 236 0.95 0.3449 
2 5 236 1.11 0.2676 
2 6 236 -1.12 0.2648 
2 7 236 -0.03 0.9776 
3 4 236 -1.52 0.1306 
3 5 236 -1.35 0.1777 
3 6 236 -3.58 0.0004 
3 7 236 -2.49 0.0134 
4 5 236 0.16 0.8692 
4 6 236 -2.06 0.0401 
4 7 236 -0.97 0.3308 
5 6 236 -2.23 0.0268 
5 7 236 -1.14 0.2557 
6 7 236 1.09 0.277 
Day Group s Group DF t Value Pr > |t| 
Day 56 
1 2 236 4.34 <.0001 
1 3 236 5.15 <.0001 
1 4 236 5.55 <.0001 
1 5 236 5.13 <.0001 
1 6 236 2.77 0.006 
1 7 236 3.64 0.0003 
2 3 236 0.81 0.4197 
2 4 236 1.21 0.2286 
2 5 236 0.78 0.4341 
2 6 236 -1.57 0.1182 
2 7 236 -0.7 0.4847 
3 4 236 0.4 0.6903 
3 5 236 -0.02 0.9803 
3 6 236 -2.38 0.0183 
3 7 236 -1.51 0.1329 
4 5 236 -0.42 0.6722 
4 6 236 -2.78 0.006 
4 7 236 -1.91 0.0577 
5 6 236 -2.35 0.0195 
5 7 236 -1.48 0.1393 
6 7 236 0.87 0.3861 
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Table 10:  Pairwise group comparisons (contd) 
Day Group s Group DF t Value Pr > |t| 
Day 98 
1 3 236 5.86 <.0001 
1 4 236 6.6 <.0001 
1 5 236 4.68 <.0001 
3 4 236 0.74 0.4606 
3 5 236 -1.19 0.237 
4 5 236 -1.92 0.0555 
Day Group s Group DF t Value Pr > |t| 
 Day 140 
1 3 236 5.85 <.0001 
1 4 236 6.75 <.0001 
1 5 236 4.18 <.0001 
3 4 236 0.9 0.3707 
3 5 236 -1.67 0.0954 
4 5 236 -2.57 0.0108 
 
Figures 16–22 show the distribution of the louse populations on the sheep pre- and post-
treatment. The top band represents the seven assessment sites at the top of each sheep, the 
middle band is the middle group of seven assessment sites and the bottom band is the 
bottom six louse assessment sites on each sheep. The parameter on the x-axis is days post-
treatment. 
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Figure 16: Mean louse counts for Group 1 (untreated control) showing the 
distribution of lice in the three counting bands 
 
Figure 17: Mean louse counts for Group 2 (FD 0184-sol-030) showing the 
distribution of lice in the three counting bands 
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Figure 18: Mean louse counts for Group 3 (FD 0184-sol-031) showing the 
distribution of lice in the three counting bands  
 
Figure 19: Mean louse counts for Group 4 (FD 0184-sol-032) showing the 
distribution of lice in the three counting bands 
 
0
20
40
60
80
100
120
140
0 14 28 42 56 70 82 98 112 126 140
M
e
an
 G
ro
u
p
 L
o
u
se
 C
o
u
n
t 
Group 3  
top
mid
bottom
0
10
20
30
40
50
60
70
80
90
100
0 14 28 42 56 70 82 98 112 126 140
M
e
an
 G
ro
u
p
 L
o
u
se
 C
o
u
n
t 
Group 4 
top
mid
bottom
Student No.: 200280002 
Scott Leigh Hackett 
December 2015 
 
Page 65 of 104 
 
 
Figure 20: Mean louse counts for Group 5 (FD 0184-sol-033) showing the 
distribution of lice in the three counting bands 
 
Figure 21: Mean louse counts for Group 6 (FD 0184-sol-034) showing the 
distribution of lice in the three counting bands 
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Figure 22: Mean louse counts for Group 7 (FD 0184-sol-035) showing the 
distribution of lice in the three counting bands 
 
 5.2. Study 2 (wool residues) 
All sheep that entered the study completed the biological phase, except sheep 9654 that died 
from acute bronchopneumonia and haemorrhage of the cranial lung lobe possibly associated 
with a concomitant anthelmintic treatment.  
Body weights (Table 22 Appendix 4) declined from day -1 to day 28 and subsequently 
increased between days 28 and 42. The initial decrease likely reflected the animals being 
shorn between weighing time points. Feed consumption was consistent throughout the study 
for all groups with approximately 1 kg of feed consumed per animal per day.   
No abnormal animal observations were recorded at any general health observation time 
point. The post-treatment observations were normal and all formulations appeared to be well 
tolerated.  
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All animals presented on days -14, -1, 28 and 42 passed their physical veterinary 
examination although the following findings were documented: animal 9639 on day -14 had a 
bleeding gum, 9669 on day -14 had a shearing cut, 9626 on day -1 had a broken left horn 
and 9630 on day 28 had a shearing cut.  
Fibre diameters are tabulated in Table 23 Appendix 4 with individual and group mean fibre 
diameters presented.  
Animal treatment details are presented in Table 11. 
The performance of the analytical method was assessed via QC samples, which were freshly 
prepared and extracted at the same time as the study samples. Sets of QCs containing each 
of the four concentration levels, at least in duplicate or more, were placed amongst study 
samples throughout the analytical run. 
Six calibration standards were freshly prepared in duplicate over the range 20.0–2000 µg/kg 
and one replicate from each concentration was analysed at the beginning and at the end of 
the analytical sequence. Both replicates (12 in total) were used to construct the calibration 
curve. 
Wool residue results are presented in Tables 12–17 and graphically in Figures 23–25. 
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Table 11: Animal treatment details 
Group 
Sheep 
number 
Sex 
Test 
item 
Weight 
(kg) at 
day -1 
Dose 
received 
(g) 
Dose 
received 
(mL) 
Actual 
dose 
(mg/kg) 
1 
9649 Male 
FD 
0184-
sol-
030 
35.8 39.9 38.8 5.4 
9639 Male 36.8 38.5 37.4 5.1 
9617 Male 37.8 39.4 38.3 5.1 
9633 Male 38.0 40.6 39.5 5.2 
2 
9634 Male 
FD 
0184-
sol-
031 
34.6 33.7 35.1 5.1 
9657 Male 35.0 33.8 35.2 5.0 
9638 Male 38.8 37.3 38.8 5.0 
9668 Male 38.8 37.5 39.1 5.0 
3 
9603 Female 
FD 
0184-
sol-
032 
36.0 34.7 36.3 5.0 
9660 Male 36.8 35.1 36.7 5.0 
9665 Male 39.2 39.7 41.6 5.3 
9654 Male 40.2 39.1 40.9 5.1 
4 
9630 Male 
FD 
0184-
sol-
033 
35.6 37.3 36.6 5.1 
9669 Male 36.4 38.8 38.1 5.2 
9628 Male 37.8 39.6 38.9 5.1 
9656 Male 41.2 45.5 44.6 5.4 
5 
9678 Male 
FD 
0184-
sol-
034 
32.6 33.6 33.2 5.1 
9642 Male 37.0 38.3 37.9 5.1 
9624 Male 38.2 41.4 40.9 5.4 
9680 Male 38.6 41.3 40.8 5.3 
6 
9601 Male FD 
0184-
sol-
035 
35.4 34.5 36.4 5.1 
9621 Male 37.2 37.2 39.3 5.3 
9677 Male 38.0 37.3 39.4 5.2 
9626 Male 44.2 43.3 45.8 5.2 
# Table rounded to one decimal point. 
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Table 12: Individual concentrations of AHC-2013 (µg/kg) in sheep wool  
 FD 0184-sol-030 FD 0184-sol-031 
Day 14 9617 9633 9639 9649 Mean 9634 9638 9657 9668 Mean 
A 1,810,000 680,000 1,450,000 675,000 1,153,750 770,000 172,000 356,000 1,700,000 749,500 
B 5500 7660 7580 11,500 8060 6100 3310 5730 2200 4335 
C 1670 2990 7110 5810 4395 8988 2560 1550 1140 3559 
Day 21           
A 7,050,000 5,190,000 3,470,000 1,750,000 4,365,000 2,430,000 1,930,000 1,700,000 962,000 1,755,500 
B 11,800 5100 4950 8840 7673 4640 5040 11,200 1850 5683 
C 985 507 3670 3120 2071 3060 1680 345 272 1339 
Day 28           
A 1,160,000 1,620,000 903,000 672,000 1,088,750 1,310,000 1,450,000 1,240,000 843,000 1,210,750 
B 19,500 6090 4370 6100 9015 4390 2070 3550 2370 3095 
C 3120 2840 3030 26,200 8798 2710 1700 2540 3270 2555 
Day 42           
A 594,000 959,000 488,000 187,000 557,000 311,000 260,000 809,000 316,000 424,000 
B 9520 3810 3880 12,900 7528 2820 3000 2810 1630 2565 
C 1540 707 3460 3270 2244 1950 418 580 344 823 
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Table 13: Individual concentrations of AHC-2013 (µg/kg) in sheep wool  
 FD 0184-sol-032 FD 0184-sol-033 
Day 14 9603 9654 9660 9665 Mean 9628 9630 9656 9669 Mean 
A 256,000 282,000 558,000 277,000 343,250 906,000 1,440,000 1,130,000 1,440,000 1,229,000 
B 2870 2080 3940 2080 2743 3210 3750 10,900 8630 6623 
C 2530 1490 3630 4430 3020 1360 3340 16,061 3132 5973 
Day 21 
          A 295,000 118,000 124,000 259,000 199,000 2,350,000 4,200,000 3,590,000 2,370,000 3,127,500 
B 2290 2410 2750 2070 2380 2560 4690 72,200 6300 21,438 
C 1100 852 292 437 670 428 1170 4210 1200 1752 
Day 28 
          A 411,000 No sample 420,000 190,000 340,333 1,040,000 1,410,000 1,510,000 941,000 1,225,250 
B 3880 No sample 1630 2070 2527 3190 5470 9180 7000 6210 
C 1420 No sample 3680 336 1812 475 3660 3780 1670 2396 
Day 42 
          A 246,000 No sample 160,000 418,000 274,667 483,000 603,000 1,290,000 2,570,000 1,236,500 
B 2590 No sample 2410 1420 2140 1500 2610 4800 1810 2680 
C 830 No sample 1690 401 974 483 2490 2710 1610 1823 
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Table 14: Individual concentrations of AHC-2013 (µg/kg) in sheep wool  
 
FD 0184-sol-034 FD 0184-sol-035 
Day 14 9624 9642 9678 9680 Mean 9601 9621 9626 9677 Mean 
A 1,760,000 1,090,000 2,030,000 1,380,000 1,565,000 1,260,000 583,000 1,850,000 775,000 1,117,000 
B 2735 4620 5420 4060 4209 4300 6230 5550 6640 5680 
C 9585 1000 1420 2340 3586 1870 5990 2230 4600 3673 
Day 21 
          
A 2,520,000 1,760,000 1,540,000 1,430,000 1,812,500 2,450,000 3,990,000 1,340,000 2,250,000 2,507,500 
B 5570 7490 10,300 3170 6633 5720 4070 40,300 9400 14,873 
C 911 881 531 1170 873 485 1890 1230 4280 1971 
Day 28 
          
A 1,370,000 1,550,000 2,180,000 440,000 1,385,000 858,000 1,010,000 1,240,000 167,000 818,750 
B 5700 8160 11,200 7730 8198 6440 4950 9560 3330 6070 
C 1900 5380 1870 1440 2648 5790 3380 3180 1320 3418 
Day 42 
          
A 827,000 2,290,000 1,240,000 506,000 1,215,750 1,150,000 958,000 912,000 812,000 958,000 
B 4770 2740 7590 2660 4440 2900 2210 3670 2040 2705 
C 2670 762 1230 586 1312 2820 2130 1790 267 1752 
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Table 15: Concentrations of AHC-2013 (µg/kg) in sheep wool (group mean by 
location and time) 
 Location 
FD 0184-sol-030 FD 0184-sol-031 FD 0184-sol-032 
Mean  Mean Mean 
Day 14 
A 1,153,750 749,500 343,250 
B 8060 4335 2743 
C 4395 3559 3020 
Day 21 
A 4,365,000 1,755,500 199,000 
B 7673 5683 2380 
C 2071 1339 670 
Day 28 
A 1,088,750 1,210,750 340,333 
B 9015 3095 2527 
C 8797 2555 1812 
Day 42 
A 557,000 424,000 274,667 
B 7527 2565 2140 
C 2244 823 974 
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Table 16: Concentrations of AHC-2013 (µg/kg) in sheep wool (group mean by 
location and time) 
 
Location 
FD 0184-sol-033 FD 0184-sol-034 FD 0184-sol-035 
Mean Mean Mean 
Day 14 
A 1,229,000 1,565,000 1,117,000 
B 6623 4209 5680 
C 5973 3586 3673 
Day 21 
A 3,127,500 1,812,500 2,507,500 
B 21438 6633 14,873 
C 1752 873 1971 
Day 28 
A 1,225,250 1,385,000 818,750 
B 6210 8198 6070 
C 2396 2648 3418 
Day 42 
A 1,236,500 1,215,750 958,000 
B 2680 4440 2705 
C 1823 1312 1752 
Table 17:  Drug concentration spreadability at day 42 
Formulation A to B B to C  A to C 
FD 0184-sol-030 1% 29% 0% 
FD 0184-sol-031 1% 25% 0% 
FD 0184-sol-032 1% 40% 0% 
FD 0184-sol-033 0% 63% 0% 
FD 0184-sol-034 0% 27% 0% 
FD 0184-sol-035 0% 49% 0% 
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Legend for Figures 23–25: Group 1 (FD 0184-sol-030) profile for location A is represented as solid 
black line with plot label 1, Groups 2 to 6 FD 0184-sol-031, FD 0184-sol-032, FD 0184-sol-033, FD 
0184-sol-034, FD 0184-sol-035 respectively profiles for location A are represented as solid lines (red, 
green, blue, pink, orange) with plot labels 2 to 6, respectively. Vertical bars indicate +/- two standard 
errors for the mean. 
Figure 23:  Mean wool residue profiles within treatment groups for location A on 
log-scale  
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Figure 24: Mean wool residue profiles with respect to treatment groups for location 
B on log-scale  
 
Figure 25: Mean wool residue profiles with respect to treatment groups for location 
C on log-scale  
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Table 18 compares the relationship between locations A, B, C within the same treatment 
group to understand if there is a statistically significance difference of drug concentrations 
between the different locations around the sheep. The nominator and denominator are the 
estimates of drug concentration and the ratio estimate is a proportion of these two factors. 
Table 18: Group by location (between different locations for same group) 
Effect Group Loc Estimate 
(nominator) 
Group Loc Estimate 
(denominator) 
Ratio of 
estimates 
p-
value 
S 
(*) 
GROUP*LOC          1 A 1188584 1 B 7228.6 164.4 <.0001 *** 
GROUP*LOC          1 A 1188584 1 C 2742.2 433.4 <.0001 *** 
GROUP*LOC          1 B 7228.6 1 C 2742.2 2.6 <.0001 *** 
GROUP*LOC          2 A 794552.7 2 B 3429.0 231.7 <.0001 *** 
GROUP*LOC          2 A 794552.7 2 C 1350.2 588.5 <.0001 *** 
GROUP*LOC          2 B 3429.0 2 C 1350.2 2.5 0.0001 *** 
GROUP*LOC          3 A 264673.0 3 B 2351.8 112.5 <.0001 *** 
GROUP*LOC          3 A 264673.0 3 C 1130.7 234.1 <.0001 *** 
GROUP*LOC          3 B 2351.8 3 C 1130.7 2.1 0.0034 ** 
GROUP*LOC          4 A 1444337 4 B 5137.9 281.1 <.0001 *** 
GROUP*LOC          4 A 1444337 4 C 1917.1 753.4 <.0001 *** 
GROUP*LOC          4 B 5137.9 4 C 1917.1 2.7 <.0001 *** 
GROUP*LOC          5 A 1353622 5 B 5312.4 254.8 <.0001 *** 
GROUP*LOC          5 A 1353622 5 C 1497.7 903.8 <.0001 *** 
GROUP*LOC          5 B 5312.4 5 C 1497.7 3.5 <.0001 *** 
GROUP*LOC          6 A 1099243 6 B 5329.8 206.2 <.0001 *** 
GROUP*LOC          6 A 1099243 6 C 2088.2 526.4 <.0001 *** 
GROUP*LOC          6 B 5329.8 6 C 2088.2 2.6 0.0001 *** 
(*) S: Significance indicates significant differences (ratio of estimates 1) as follows: * for 0.01  p < 0.05, ** for 0.001   
p < 0.01 and *** for p < 0.001; abbreviation: LOC: Location 
Table 19 compares the relationship between drug concentration within the same location 
against treatment group to determine if there is a statistically significance difference of drug 
concentrations at the same location between treatment groups. 
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Table 19: Group by location (between different groups for same location) 
 Effect Group Loc Estimate 
(nominator) 
Group Loc Estimate 
(denominator) 
Ratio of 
estimates 
p-value S (*) 
GROUP*LOC          1 A 1188584 2 A 794552.7 1.50 0.0896  
GROUP*LOC          1 A 1188584 3 A 264673.0 4.49 <.0001 *** 
GROUP*LOC          1 A 1188584 4 A 1444337 0.82 0.4041  
GROUP*LOC          1 A 1188584 5 A 1353622 0.88 0.5768  
GROUP*LOC          1 A 1188584 6 A 1099243 1.08 0.7370  
GROUP*LOC          1 B 7228.6 2 B 3429.0 2.11 0.0026 ** 
GROUP*LOC          1 B 7228.6 3 B 2351.8 3.07 <.0001 *** 
GROUP*LOC          1 B 7228.6 4 B 5137.9 1.41 0.1479  
GROUP*LOC          1 B 7228.6 5 B 5312.4 1.36 0.1905  
GROUP*LOC          1 B 7228.6 6 B 5329.8 1.36 0.1951  
GROUP*LOC          1 C 2742.2 2 C 1350.2 2.03 0.0041 ** 
GROUP*LOC          1 C 2742.2 3 C 1130.7 2.43 0.0007 *** 
GROUP*LOC          1 C 2742.2 4 C 1917.1 1.43 0.1298  
GROUP*LOC          1 C 2742.2 5 C 1497.7 1.83 0.0128 * 
GROUP*LOC          1 C 2742.2 6 C 2088.2 1.31 0.2457  
GROUP*LOC          2 A 794552.7 3 A 264673.0 3.00 <.0001 *** 
GROUP*LOC          2 A 794552.7 4 A 1444337 0.55 0.0138 * 
GROUP*LOC          2 A 794552.7 5 A 1353622 0.59 0.0269 * 
GROUP*LOC          2 A 794552.7 6 A 1099243 0.72 0.1683  
GROUP*LOC          2 B 3429.0 3 B 2351.8 1.46 0.1253  
GROUP*LOC          2 B 3429.0 4 B 5137.9 0.67 0.0883  
GROUP*LOC          2 B 3429.0 5 B 5312.4 0.65 0.0660  
GROUP*LOC          2 B 3429.0 6 B 5329.8 0.64 0.0641  
GROUP*LOC          2 C 1350.2 3 C 1130.7 1.19 0.4649  
GROUP*LOC          2 C 1350.2 4 C 1917.1 0.70 0.1376  
GROUP*LOC          2 C 1350.2 5 C 1497.7 0.90 0.6561  
GROUP*LOC          2 C 1350.2 6 C 2088.2 0.65 0.0670  
GROUP*LOC          3 A 264673.0 4 A 1444337 0.18 <.0001 *** 
GROUP*LOC          3 A 264673.0 5 A 1353622 0.20 <.0001 *** 
GROUP*LOC          3 A 264673.0 6 A 1099243 0.24 <.0001 *** 
GROUP*LOC          3 B 2351.8 4 B 5137.9 0.46 0.0025 ** 
GROUP*LOC          3 B 2351.8 5 B 5312.4 0.44 0.0017 ** 
GROUP*LOC          3 B 2351.8 6 B 5329.8 0.44 0.0016 ** 
GROUP*LOC          3 C 1130.7 4 C 1917.1 0.59 0.0345 * 
GROUP*LOC          3 C 1130.7 5 C 1497.7 0.75 0.2497  
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 Effect Group Loc Estimate 
(nominator) 
Group Loc Estimate 
(denominator) 
Ratio of 
estimates 
p-value S (*) 
GROUP*LOC          3 C 1130.7 6 C 2088.2 0.54 0.0150 * 
GROUP*LOC          4 A 1444337 5 A 1353622 1.07 0.7803  
GROUP*LOC          4 A 1444337 6 A 1099243 1.31 0.2447  
GROUP*LOC          4 B 5137.9 5 B 5312.4 0.97 0.8858  
GROUP*LOC          4 B 5137.9 6 B 5329.8 0.96 0.8747  
GROUP*LOC          4 C 1917.1 5 C 1497.7 1.28 0.2920  
GROUP*LOC          4 C 1917.1 6 C 2088.2 0.92 0.7132  
GROUP*LOC          5 A 1353622 6 A 1099243 1.23 0.3732  
GROUP*LOC          5 B 5312.4 6 B 5329.8 1.00 0.9888  
GROUP*LOC          5 C 1497.7 6 C 2088.2 0.72 0.1586  
(*) S: Significance indicates significant differences (ratio of estimates 1) as follows: * for 0.01  p < 0.05, ** for 0.001   
p < 0.01 and *** for p < 0.001; abbreviation: LOC: Location 
The underlying normal distribution assumptions for the applied RMANOVA model were 
satisfied with a Shapiro-Wilk p-value of 0.1628.The three-way interaction; group by day by 
location and the two-way interaction; group by day were not significant (p > 0.47). The main 
effects day, group and location are highly significant but since the two-way interactions group 
by location and day by location are significant, only these two-way interactions are further 
evaluated. 
Contrasts for factor day by location (between different locations for same day): For all 
considered days (14, 21, 28, 42), the estimated concentration ratios of location A over 
location B, location A over location C and location B over location C were significantly higher 
than 1. The size orders of these ratios were A/B: (173.5–267.2), A/C: (273.4–1519.5) and 
B/C: (1.5–5.7). 
Contrasts for factor day by location (between different days for same location)were  location 
A,  significantly higher levels on day 21 in comparison to all other days. For location B, there 
were significantly higher levels on days 14, 21 and 28 in comparison to day 42.  
For location C, there were significantly higher levels on day 14 in comparison to days 21 and 
42. Day 21 levels were significantly lower in comparison to day 28. 
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Contrasts for factor group by location (between different locations for same group) were for 
all six groups, the estimated concentration ratios of location A over location B, location A 
over location C and location B over location C were significantly higher than 1. The size 
orders of these ratios were A/B: (112.5–281.1), A/C: (234.1–903.8) and B/C: (2.1–3.5). 
Contrasts for factor group by location (between different groups for same location) for 
location A,  significantly higher levels in Groups 1, 2, 3, 4 and 5 were found in comparison to 
Group 3 while significantly higher levels in Groups 4 and 5 in comparison to Group 2 were 
found. For location B, there were significantly higher levels in Group 1 in comparison to 
Groups 2 and 3, and significantly higher levels in Groups 4, 5 and 6 in comparison to Group 
3. For location C, there were significantly higher levels in Group 1 in comparison to Groups 2, 
3 and 5, and significantly higher levels in Groups 4 and 6 in comparison to Group 3. Refer to 
Table 11 for formulation number/treatment group codes. 
5.3. Study 3 (scourability) 
All sheep that entered into the study completed the biological phase. Animals passed their 
physical veterinary examinations on days -14, -1, 42, 70 and 98. The animals’ body weights 
increased during the biological phase and no abnormal animal observations were recorded 
at any post-treatment observation time point (Table 23 Appendix 5). Wool fibre diameter 
ranged from 13.9 µm to 17.5 µm across all groups (Table 24 Appendix 5). Mean wool fibre 
length for all groups was 26.2 mm on day 42 developing to 42.2 mm on day 98 (Table 25 
Appendix 5). All wool specimens taken at day 42 were analysed under AS 4054-1992 for low 
and high temperature scourability (Table 20). 
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Table 20: Staining scale ratings according to Australian standard (AS 4054-1992) 
Group  
(formulation) 
Animal 
number 
Stain rating  
(as received)  
Stain rating  
(low temperature) 
Stain rating 
 (high temperature) 
1 
(FD 0184-sol-030) 
9618 5 5 5 
9675 4-5 5 5 
9659 5 5 5 
Mean 4.8 5.0 5.0 
2 
(FD 0184-sol-031) 
9614 4-5 5 5 
9616 5 5 5 
9611 5 5 5 
Mean 4.8 5.0 5.0 
3 
(FD 0184-sol-032) 
9632 5 5 4-5 
9615 4 4-5 5 
9631 4-5 5 5 
Mean 4.5 4.8 4.8 
4 
(FD 0184-sol-033) 
9676 5 5 5 
9605 5 5 5 
9667 5 5 5 
Mean 5.0 5.0 5.0 
5 
(FD 0184-sol-034) 
9645 4-5 5 5 
9682 5 5 5 
9619 5 5 5 
Mean 4.8 5.0 5.0 
6 
(FD 0184-sol-035) 
9670 5 5 5 
9608 5 5 5 
9653 4 5 5 
Mean 4.6 5.0 5.0 
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6. Discussion  
6.1. Study 1 (efficacy) 
Predictably, mean louse counts were reduced significantly in the control group after shearing, 
a process which effectively removes a proportion of the parasite population. A typical 
reduction is 30–50% (Joshua et al., 2010). In the present study, mean louse counts of the 
control group were reduced by 31.8% by 14 days after shearing, 52.2% by 28 days from 
shearing and peaking at 52.5% on day 56 post-shearing. The decline in mean louse count 
started to stabilize by day 42 (51.5%) with further subtle declines up to day 56. This trend of 
population decline stopped at day 70 post-shearing when an increase in the mean louse 
population was observed. Joshua et al., (2010) found louse populations in untreated shorn 
animals slowly increased following shearing until approximately 90 days post-shearing at 
which time population increase accelerated. This trend follows a similar pattern to that 
observed in Study 1. It is probable the reversal in trend was due to an increase in wool length 
and therefore louse habitat coupled with a possible reduction in overall chemical residue 
after measures ceased on day 42. 
Individual group louse counts indicated that no treatment fully controlled the louse 
populations on the sheep for the regulatory required 20 week period (for an off-shears 
product). Formulations FD 0184-sol-31, FD 0184-sol-32, FD 0184-sol-33 (Groups 3, 4 and 5, 
respectively) were the most effective at reducing the louse populations and appear to be the 
lead formulations for further investigation. With that said there were statistically significant 
differences between these formulations. 
There were no significant differences between formulations FD 0184-sol-31 and FD 0184-
sol-32, and FD 0184-sol-31 and FD 0184-sol-33. There was a significant difference between 
FD 0184-sol-32 and FD 0184-sol-33. This directs that FD 0184-sol-32 is likely to be the 
preferred candidate to pursue further. 
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The difference in efficacy between FD 0184-sol-31 and FD 0184-sol-32 is low, i.e. 1.1%. The 
lack of significance between FD 0184-sol-31 and FD 0184-sol-33 is therefore likely to be due 
to the variation in louse counts in these two groups on day 140, which were: 
FD 0184-sol-31 – 2, 1, 0, 12 and 18 (mean 6.6); 
FD 0184-sol-33 – 67, 1, 1, 32 and 59 (mean 32.0). 
It was be noted this conclusion is on the basis of one study with small treatment group 
numbers (n=5 sheep) and further investigation comparing formulations FD 0184-sol-31 and 
FD 0184-sol-32 are therefore justified. 
Although 100% efficacy was never consistently achieved and may be an impossible goal in 
reality, there was generally less lice present in the treatment application area (i.e. backline) 
compared to the areas further removed from the application site. This would suggest that the 
formulations displayed good louse control directly within the application site and that the 
formulations may not have been sufficiently distributed on the skin and within the fleece to 
achieve full louse control across the whole body. This would need to be addressed and 
evaluated through a wool residue depletion study as outlined in Study 2 with extended 
sample time points from treatment so a dose limiting effect may be evaluated in all areas 
around the sheep.  
The current study indicated that the much lower concentrations of the active, distant from the 
application site also gave high levels of protection (formulation FD 0184-sol-031 (louse count 
of 1/drug concentration 2565 µg/kg), FD 0184-sol-032 (louse count of 2/drug concentration 
2565 µg/kg), FD 0184-sol-033 (louse count of 1/drug concentration  
2680 µg/kg) in comparison to the control group, which had a louse count of 50 in the flank 
and belly locations over a 42 day period of the study.  
Figure 16 (untreated control group) indicates the normal spatial distribution of lice is 
concentrated along the backline closely followed by the mid-line flank, and the parasite 
marginally populates the belly area.  
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This ‘normal’ distribution was disrupted by the spray-on treatment to the backline, as the mid-
line became the most populated area on the sheep in most treated groups (Figures 17–22). 
Louse populations on the backline became comparable and below that of the mid-line flank 
populations, which confirms a treatment effect. This disruption to normal spatial distribution 
correlates with drug residue profiles where chemical concentrations were significantly higher 
across the treated groups in wool from the backline when compared to wool from the mid-line 
and bellies.  
An efficacy of 100% was not achieved with any of the formulations and less than 1% of the 
applied active ingredient migrated from the application area to the belly region over a 42 day 
period in all treated groups. This was reflected in a relatively stable louse population in the 
belly region in all treated groups. The results suggest that while more ‘migratory’ formulations 
could improve overall louse control, reaching 100% efficacy with this active ingredient 
presents a distinct challenge. Given lice were still found in pockets within the application 
area, improvements to the application method may be beneficial, e.g. use of high volume 
products, but more likely, testing the same formulations with a different active ingredient (if 
compatibility between the active and excipients was evident) with proven efficacy of 100% 
would give greater confidence to have elicit efficacy in regions remote from the site of 
application.  
The formulations were well tolerated by the sheep with no reactions observed at any stage of 
the study that were considered to be related to the application of the products.  
Overall, no formulation tested in this study was able to demonstrate 100% efficacy at  
20 weeks post-treatment against naturally occurring infestations of B. ovis when applied at a 
dose of 5 mg/kg. With this finding, none of the formulations meet the criteria for an off-shears 
control claim as defined in the WAAVP guidelines for sheep ectoparasiticides (Holdsworth  
et al., 2006).  
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6.2. Study 2 (wool residues) 
The residue concentrations were considerably higher at location A (close to application site), 
as compared to locations B and C, throughout the study. Residue depletion was slow  
(e.g. from day 28 to 42) so only limited conclusions can be drawn with regard to depletion in 
the absence of any time points beyond day 42. Highest AHC-2013 levels were observed on 
day 21 for locations A and B (exception: FD 0184-sol-032), whereas for location C the 
highest levels were observed on days 14 and 28 with a temporary minimum on day 21 for all 
groups. This unusual time dependency might originate from the variability inherent to the 
sampling procedure (different location at each time point).  
Although a relatively slow drug residue depletion is desirable for persistent efficacy it could 
have potential environmental, and health and safety implications, which impact the Wool 
Harvesting Interval, Wool Rehandling Interval and potentially the Export Slaughter Interval 
(each parameter being assessed by the APVMA in the course of product registration). This 
low drug depletion rate should be a consideration in the design of future residue studies and 
particularly the timing of wool collections.  
In examining the interaction between louse numbers and drug concentrations, it was 
demonstrated that even at the highest drug concentrations in wool there were still small 
populations of lice found. This suggests that even if a formulation had better migratory 
characteristics it would still not provide sufficient efficacy to meet the current regulatory 
requirements for registration.  
The louse population was highest within the backline areas in the untreated control group 
followed by the flanks and the smallest populations were found in the belly/lower region of 
the sheep. This knowledge of the ‘normal’ spatial distribution of the population should assist 
the efficacy of spray-on formulations as the largest population of lice would come in contact 
with the highest concentrations of the drug.  
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In contrast, within all treated groups the spatial distribution of the louse population varied 
from the control group in that the highest populations of lice were found in the flank region 
and not on the backline. This is attributed to the higher drug concentration found on the 
backline following treatment.  
One of the interesting trends during the course of treatment was the numbers of lice in the 
treatment zone over time. In the control group (Figure 16), similar numbers of lice were often 
detected on the back and flank, with low numbers on the belly. Over time in the treated 
groups, the actual numbers were highest on the flank (Figures 20–-23) and for formulation 
FD-0184-sol-033, the flank numbers actually increased disproportionately after day 70 
(Figure 20).  
One potential explanation for this observation is the reduced drug concentration on the flank 
region in comparison to the backline was not adequate to kill the local lice allowing these lice 
to re-populated over this period to their ‘normal’ spatial distribution when drug concentration 
was non-lethal.  
Drug concentrations were only measured at these sites until day 42, so the interaction 
between louse recovery and drug concentrations after this period could not be examined. For 
the flank location, there were significantly higher levels (p < 0.05) of drug detected on days 
14, 21 and 28 in comparison to day 42, which confirms the drug depleted from the flank. This 
supports the potential explanation for the increasing louse numbers over time.  
There is also a statistically significant treatment effect on the louse population across all 
treatment groups (p < 0.05) in comparison to the control group through days 14, 21 and 42, 
which confirms the treatments were effective to varying degrees during the study. As an 
example of the complexities in this analysis, formulation FD 0184-sol-032 had the lowest 
drug concentration in flank wool yet it was one of the most efficacious formulations. It would 
appear, that in addition to drug concentrations, other factors may be influencing efficacy,  
e.g. animal conformation, consistency and design of product application and pre-existing 
louse populations.  
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Product application is a major factor, which influences efficacy and potentially subjects the 
lice to sub-lethal drug concentrations. Inappropriate application of the formulation on the 
backline and/or poor spreadability over the sheep can result in sub-optimal chemical 
concentration gradients, which can reduce efficacy and enable resistance to develop (James, 
2011c). Holdsworth et al. (2006) specifically emphasise the importance of animal selection 
and the calculation of efficacy when evaluating ectoparasiticides.  
It was considered that these potential factors were managed within the design and during the 
implementation of the study, and it is therefore difficult to explain the relationship between 
efficacy and drug concentrations in the wool – highlighting the need for more specific 
investigation of wool residues with multiple replicates (including increased sheep numbers) 
over a longer duration.  
The possibilities of the applied drug being transdermally absorbed and subsequently 
excreted over time from the skin and wool follicles or the active ingredient being retained on 
the wool tip and not migrating down the wool staple as wool length increases, i.e. forming a 
‘canopy layer’, should be investigated.  
Of the formulations evaluated, drug migration was found to be relatively poor with only one 
treated group (FD 0184-sol-030) having drug movement over 1% (Concentration B/A*100) 
from location A to location B over a 42 day period. In all other groups the total drug migration 
was less than 1%. Drug migration from location A to location C was less than 1% in all 
groups over 42 days however drug migration from location B to C varied markedly with 
migrations up to 63% (Concentration C/B*100; FD 0184-sol-032) and down to 25% (FD 
0184-sol-030).  
The residue/migration study fulfilled the objective of finding what drug concentrations were at 
given locations on the sheep at defined time points. The concentrations found in wool were 
unusual in that they did not peak at the first time point, which has been the case in studies 
with several other molecules.  
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Peaks at body locations A and B were seen on day 21 and not day 14, which may be 
attributed to the non-randomized approach in sample location selection combined with the 
application method. This could potentially influence or skew drug concentrations and 
therefore it should be a consideration for future studies that wool sample locations are 
randomized rather than sequentially taken. In the case of location C the highest drug level 
concentration levels were observed on days 14 and 28 with a temporary minimum on day 21 
for all groups. This unusual time dependency might originate from the variability inherent to 
the sampling procedure (different location at each time point). This should also be a 
consideration for future wool residue type studies in that replicates could be used so that 
essentially the same location could be sampled at different time points throughout the study. 
6.3. Study 3 (scourability) 
This study examined the scourability of colouring agent from the wool of sheep treated with 
experimental formulations of AHC-2013. The study found wool specimens taken 42 days 
post-treatment were scourable for all treatments groups. As such no additional wool 
specimen analysis was required as initially planned in the study design.   
The confirmed scourability answered the objective of the study and confirmed the 
commercial processing acceptability of all formulations. Future investigations could establish 
scourability prior to 42 days post-treatment but in the practical sense this information would 
not be critical to the farmer. 
7. Conclusion  
Formulations FD 0184-sol-31, FD 0184-sol-32, FD 0184-sol-33 are the preferred 
formulations considered for optimization at equivalent and higher doses but noting that the 
statistical differences identified cast doubt on FD 0184-sol-33.  
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At the evaluated dose it was demonstrated that even in the most drug concentrated wool 
there were still small populations of lice found. This finding suggests that even if a 
formulation had better migratory characteristics this would still not provide high enough 
efficacy for registration in Australia.  
It was demonstrated that the current formulations had limited spread and therefore both the 
application method and formulations need to be evaluated in combination should 
development work on AHC-2013 continue. Although the spray-on application method has 
many advantages to the end consumer it is not the only option available for application and 
alternatives such as higher spray-on dose and jetting should also be considered.  The slow 
drug depletion across all formulations, although desirable for persistent efficacy, could have 
potential environmental, and health and safety implications, which impact the Wool 
Harvesting Interval, Wool Rehandling Interval and potentially the Export Slaughter Interval. 
This low drug depletion rate should be a consideration in the design of future residue studies 
and particularly the timing of wool collections. Should a higher dose be evaluated in the 
future, the drug concentrations found in wool and relative efficacy (from the current studies) 
should be taken into consideration when establishing dose and evaluating feasibility through 
a cost of goods analysis, environmental impact and drug safety review.  
The feasibility of having adequate levels of drug at locations B and C from a higher dose 
must be made, however it is difficult to see drug concentrations at these locations being high 
enough to be efficacious without a significant increase in AHC-2013 applied or a change in 
application method. Modelling of drug concentrations in wool and relative efficacy could 
assist in determining dose however, as seen within the efficacy and residue studies 
described herein there is a relationship between louse population and drug concentration in 
wool within a treated group and in comparison to the untreated controls. The response effect 
is quite variable between groups and would be difficult to achieve without further in vivo 
evaluation.  
  
Student No.: 200280002 
Scott Leigh Hackett 
December 2015 
Page 89 of 104 
 
It could be assumed from the consistent scourability that the active ingredient and excipients 
used did not influence binding of the colouring agent to the wool fibre. This is an important 
consideration for commercial formulations and given this finding it would be prudent to use 
the same colouring agent in any future formulations.  
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Appendix 1 – Statistical report 
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Appendix 2 – AWTA report 
  
  
Student No.: 200280002 
Scott Leigh Hackett 
December 2015 
Page 98 of 104 
 
Appendix 3 – Study 1 results 
Table 21: Arithmetic mean group live weights and weight gain (kg) 
Group Treatment 
Arithmetic mean Day final weight 
observed 
Average 
gain/day (kg) Day -5 Final weight 
1 Control 53.9 63.4 140 0.07 
2 FD 0184-sol-030 59.0 59.5 56 0.01 
3 FD 0184-sol-031 58.2 66.7 140 0.06 
4 FD 0184-sol-032 61.6 69.3 140 0.05 
5 FD 0184-sol-033 58.0 66.7 140 0.06 
6 FD 0184-sol-034 59.0 60.7 56 0.03 
7 FD 0184-sol-035 58.5 59.2 56 0.01 
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Appendix 4 – Study 2 results 
Table 22: Body weights (kg) 
Formulation Animal number Day -1 Day 28 Day 42 
1 
(FD 0184-sol-030) 
 
9617 42.4 37.2 39.0 
9633 38.8 38.0 39.0 
9639 42.8 40.8 40.0 
9649 40.0 37.6 36.6 
Mean 41.0 38.4 38.6 
2 
(FD 0184-sol-031) 
 
9634 37.8 37.8 37.8 
9638 42.2 42.2 44.2 
9657 40.0 35.2 35.8 
9668 42.8 39.4 39.4 
Mean 40.7 38.6 39.3 
3 
(FD 0184-sol-032) 
 
9603 39.8 37.4 38.2 
9654 43.8 * * 
9660 38.8 39.0 40.6 
9665 42.6 40.6 38.4 
Mean 40.4 39.0 39.1 
4 
(FD 0184-sol-033) 
 
9628 41.0 39.2 39.6 
9630 39.0 34.0 33.4 
9656 45.2 46.4 45.8 
9669 41.6 37.2 39.0 
Mean 41.7 39.2 39.4 
5 
(FD 0184-sol-034) 
 
9624 42.6 41.2 41.8 
9678 37.8 32.4 33.0 
9680 42.2 39.8 40.4 
9642 40.6 36.4 35.6 
Mean 40.8 37.4 37.7 
6 
(FD 0184-sol-035) 
 
9601 39.6 38.8 38.2 
9621 41.6 # 35.2 
9626 47.2 38.2 47.8 
9677 40.8 37.6 39.8 
Mean 42.5 38.2 41.9 
# Weight not recorded (excluded from group mean). 
* Animal died (excluded from group mean). 
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Table 23: Fibre diameter (individual and group mean) 
Group/Formulation Animal number Fibre diameter 
1 
(FD 0184-sol-030) 
 
9617 14.6 
9633 17.0 
9639 16.4 
9649 15.7 
Mean 15.9 
2 
(FD 0184-sol-031) 
 
9634 15.0 
9638 15.1 
9657 16.0 
9668 16.7 
Mean 15.7 
3 
(FD 0184-sol-032) 
 
9603 15.9 
9654 14.9 
9660 14.6 
9665 13.9 
Mean 14.8 
4 
(FD 0184-sol-033) 
 
9628 16.2 
9630 13.8 
9656 14.2 
9669 16.5 
Mean 15.2 
5 
(FD 0184-sol-034) 
 
9624 14.6 
9678 14.2 
9680 17.5 
9642 14.5 
Mean 15.2 
6 
(FD 0184-sol-035) 
 
9601 15.4 
9621 16.1 
9626 15.9 
9677 18.0 
Mean 16.3 
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Table 24: QC samples spiked with AHC-2013 
Fortification of AHC-2013 
concentration (µg/kg) 
Found QC (%) Mean (%) CV (%) 
20 
114, 119, 101, 63.1, 98.5, 81.1, 100, 
91.4 
96.01 18.57 
60 94.6, 102, 94.2, 97.8, 99, 123, 92.8 100.48 10.37 
600 
103, 102, 100, 101, 103, 118, 98.1, 
109, 101 
103.90 5.85 
2000 103, 95.5, 95, 111, 92.3, 107, 90.1 99.12 7.98 
Overall mean and CV (%) 99.88 10.70 
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Appendix 5 – Study 3 results 
Table 25: Body weights (kg) 
Group/Formulation 
Animal 
number 
Day -1 Day 42 Day 70 Day 98 
1 
(FD 0184-sol-030) 
9618 38.0 44.6 * 48.0 
9675 40.8 47.2 49.0 51.5 
9659 39.6 43.2 45.2 45.0 
Mean 39.4 45.0 47.1 48.1 
2 
(FD 0184-sol-031) 
9614 41.4 50.0 52.0 55.5 
9616 40.8 45.6 48.2 47.4 
9611 36.6 45.4 46.2 49.2 
Mean 39.6 47.0 48.8 50.7 
3 
(FD 0184-sol-032) 
9632 36.6 44.2 47.8 50.5 
9615 38.8 46.2 48.6 50.5 
9631 39.2 45.0 47.6 49.6 
Mean 38.2 45.1 48.0 50.2 
4 
(FD 0184-sol-033) 
9676 38.2 48.4 50.5 55.0 
9605 36.2 42.2 42.4 45.8 
9667 40.8 49.2 50 53.5 
Mean 38.4 46.6 47.6 51.4 
5 
(FD 0184-sol-034) 
9645 38.0 48.2 51.0 53.0 
9682 41.4 51.0 52.0 51.5 
9619 35.2 41.2 43.2 44.2 
Mean 38.2 46.8 48.7 49.5 
6 
(FD 0184-sol-035) 
9670 35.4 43.6 45.2 47.2 
9608 39.4 46.2 50.5 52.0 
9653 36.4 48.8 47.8 49.8 
Mean 37.0 46.2 47.8 49.6 
* Body weight not taken 
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Table 26: Fibre diameter (µm, individual and group mean) 
Group (formulation) Animal number Fibre diameter  
1 
(FD 0184-sol-030) 
9618 15.5 
9675 17.4 
9659 16.3 
Mean 16.4 
2 
(FD 0184-sol-031) 
9614 15.3 
9616 15.8 
9611 13.9 
Mean 15.0 
3 
(FD 0184-sol-032) 
9632 14.5 
9615 14.6 
9631 16.2 
Mean 15.1 
4 
(FD 0184-sol-033) 
9676 14.3 
9605 17.4 
9667 15.7 
Mean 15.8 
5 
(FD 0184-sol-034) 
9645 15.8 
9682 17.5 
9619 14.6 
Mean 15.9 
6 
(FD 0184-sol-035) 
9670 15.5 
9608 16.2 
9653 15.1 
Mean 15.6 
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Table 27: Fibre length (mm) 
Group  
(formulation) 
Animal 
number 
Fibre length 
day 42 
Fibre length 
day 70 
Fibre length 
day 98 
1 
(FD 0184-sol-030) 
9618 20 31 40 
9675 23 40 42 
9659 25 30 50 
Mean 22.6 33.6 44.0 
2 
(FD 0184-sol-031) 
9614 20 33 40 
9616 25 30 30 
9611 25 40 40 
Mean 23.3 34.3 36.6 
3 
(FD 0184-sol-032) 
9632 20 30 35 
9615 30 32 42 
9631 22 30 40 
Mean 24.0 30.6 39.0 
4 
(FD 0184-sol-033) 
9676 22 30 45 
9605 30 35 45 
9667 30 30 40 
Mean 27.3 31.6 43.3 
5 
(FD 0184-sol-034) 
9645 30 30 50 
9682 20 35 40 
9619 30 30 40 
Mean 26.6 31.6 43.3 
6 
(FD 0184-sol-035) 
9670 30 35 45 
9608 35 31 50 
9653 35 30 45 
Mean 33.3 32.0 46.6 
 
 
